TSS:Rfhg 4300.1

Basic information about the TSS

---

TSS ID: rfhg_4300.1 Species: human Chr: chr1		Start: 28737768 End: 28737781 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS (EH38D2144293,EH38E1332503)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000475796.5:-18 ENST00000476976.1:-18 GeneID: 51441 HGNC/MGI_ID: HGNC:31675 UniProt_ID: Nearer transcript ids and distances:

Gene_name: YTH N6-methyladenosine RNA binding protein 2 Gene_symbol: YTHDF2 Gene_synonyms: CAHL HGRG8 NY-REN-2 Gene_source: HGNC:31675

TATA-Box annotation

---

Distance to TSS:	834
Nearest PromoterID:	NM_001172828
Entrez ID:	51441
Nearest Unigene:	Hs.532286
Nearest Refseq:	NM_016258
Nearest Ensembl:	ENSG00000198492
Gene Name:	YTH N6-methyladenosine RNA binding protein 2
Gene Alias:	CAHL|HGRG8|NY-REN-2
Gene Type:	protein-coding
CpG%:	0.076923
GC%:	0.500000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@YTHDF2 p2@YTHDF2 p3@YTHDF2 p4@YTHDF2 p5@YTHDF2 p6@YTHDF2 p7@YTHDF2
Sample		p1@YTHDF2	p2@YTHDF2	p3@YTHDF2	p4@YTHDF2	p5@YTHDF2	p6@YTHDF2	p7@YTHDF2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	60.19	22.99	8.57	13.83	6.62	1.75	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	65.35	22.86	8.30	11.13	7.28	2.43	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	60.57	23.53	5.21	11.77	10.22	1.93	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	64.87	23.70	5.61	11.02	10.19	3.53	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	58.94	26.77	7.65	13.72	7.87	2.25	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	53.49	20.16	6.01	10.66	7.75	2.33	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	73.64	28.32	9.37	12.86	10.24	4.14	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	63.22	20.10	6.30	15.50	8.96	4.60	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	74.37	25.86	8.12	13.25	8.12	4.70	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	59.70	31.30	6.38	26.08	10.43	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	60.23	29.10	5.66	17.79	8.89	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	69.11	32.12	7.32	29.27	6.50	2.85	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	51.58	6.45	2.74	0.00	0.00	1.13	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	37.89	4.96	1.50	0.15	0.00	1.80	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	46.33	6.15	1.76	0.44	0.22	1.10	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	40.24	6.79	2.01	0.25	0.00	0.75	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	34.73	4.80	2.40	0.22	0.00	1.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	33.32	5.06	2.95	0.00	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	30.92	5.33	3.20	0.53	0.00	3.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	40.02	5.27	2.71	0.45	0.00	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	42.10	6.01	1.20	0.13	0.13	1.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	38.32	6.90	1.90	1.21	0.17	1.73	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	46.40	6.98	1.29	0.78	0.13	0.90	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	36.16	4.13	2.43	0.24	0.00	0.97	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	45.41	7.48	3.10	0.52	0.00	2.06	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	44.63	9.81	1.58	0.63	0.00	1.58	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	41.76	7.14	1.10	0.55	0.00	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	51.63	6.84	2.36	0.24	0.24	1.89	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	46.03	6.46	1.13	0.00	0.32	2.26	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	46.69	5.97	2.35	0.54	0.00	1.27	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	49.41	7.54	1.47	0.42	0.00	1.47	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	45.72	7.62	1.95	0.59	0.39	0.78	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	48.33	8.44	1.90	0.21	0.21	1.69	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	40.41	7.09	1.81	0.00	0.00	1.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	42.07	6.54	1.87	1.31	0.00	1.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	46.18	8.43	3.07	0.96	0.57	1.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	44.96	7.77	2.66	0.20	0.61	1.43	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	46.34	8.06	1.61	0.60	0.20	1.01	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	45.11	5.94	1.35	0.81	0.54	2.43	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	47.29	7.20	1.20	0.96	0.00	1.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	42.35	7.29	1.65	1.41	0.00	2.35	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	44.06	6.00	1.61	0.44	0.29	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	46.82	9.49	1.69	0.63	0.21	1.05	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	47.55	9.97	1.05	0.17	0.00	1.05	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	52.20	8.63	1.81	1.00	0.20	1.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	45.37	10.24	2.09	0.00	0.00	1.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	54.46	7.20	1.68	0.48	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	49.48	8.35	2.09	0.30	0.00	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	47.40	9.57	1.68	0.00	0.00	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	38.22	9.30	1.62	1.01	0.00	1.21	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	36.69	6.15	1.64	0.61	0.00	1.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	38.25	7.34	1.56	0.00	0.00	2.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	41.16	6.39	1.77	1.06	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	37.12	3.98	1.33	0.00	0.00	1.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	18.46	1.68	0.84	0.00	0.84	3.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.07	2.30	0.00	0.00	0.00	2.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	39.22	3.24	0.97	0.00	0.00	1.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	44.96	2.57	2.57	0.00	0.00	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	20.43	3.14	1.26	0.00	0.00	2.83	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	57.81	13.40	0.71	0.71	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	50.47	7.29	0.56	0.00	0.56	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	13.53	1.59	0.80	0.00	0.00	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	18.01	2.72	0.68	0.00	0.00	1.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	31.84	2.92	1.30	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	29.82	2.48	0.71	0.35	0.35	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	15.79	7.90	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	34.13	2.93	0.49	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	34.71	2.48	1.49	0.50	0.00	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	26.27	2.35	0.00	0.47	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	13.58	1.66	0.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	26.29	3.71	0.00	0.00	0.00	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	34.24	2.45	0.00	0.31	0.00	0.00	0.31
Adipocyte - breast, donor1	11376-118A8	35.00	6.34	2.53	0.79	0.00	0.95	0.32
Adipocyte - breast, donor2	11327-117E4	30.64	5.13	1.76	0.32	0.16	0.32	0.16
Adipocyte - omental, donor1	11473-119C6	32.06	5.60	2.16	0.25	0.00	0.51	0.13
Adipocyte - omental, donor2	11474-119C7	36.63	3.74	0.75	0.00	0.00	1.49	0.00
Adipocyte - omental, donor3	11475-119C8	43.87	3.35	3.35	0.67	0.00	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	38.92	7.66	2.55	0.64	0.00	1.91	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	2.20	0.00	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	32.07	2.71	2.26	1.35	0.00	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	29.89	3.48	2.09	0.17	0.00	0.17	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	43.03	5.67	5.08	0.78	0.20	2.15	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	46.33	5.92	1.29	0.26	0.00	3.09	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	37.91	6.97	2.23	0.28	0.00	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	42.91	10.58	4.11	0.00	0.00	2.35	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	37.40	7.24	3.14	0.64	0.00	1.93	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	40.67	4.20	1.61	0.32	0.00	2.26	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	43.19	4.27	1.60	0.53	0.00	3.20	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	40.62	7.23	2.23	0.00	0.00	1.11	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	52.40	5.41	2.91	0.00	0.00	2.50	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	44.21	3.27	1.51	0.25	0.00	1.51	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	33.05	4.58	1.31	0.33	0.00	1.31	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	40.80	3.04	0.91	0.00	0.30	1.83	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	33.59	5.08	5.08	0.44	0.66	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	20.80	1.43	2.15	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	11.98	2.40	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	36.88	7.74	1.98	0.54	0.54	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	26.78	0.00	1.67	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	28.97	6.16	1.23	0.21	0.21	0.62	0.00
Anulus Pulposus Cell, donor1	11248-116E6	48.63	5.84	1.83	0.34	0.11	0.57	0.46
Anulus Pulposus Cell, donor2	11463-119B5	44.82	5.63	1.22	0.24	0.00	0.24	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	23.81	7.19	1.35	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	30.39	6.95	3.47	0.43	0.43	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	10.70	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	25.71	5.08	1.79	0.60	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	20.23	2.53	1.26	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	31.02	3.30	1.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	27.29	5.85	0.65	0.00	0.00	0.32	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	25.24	4.37	1.46	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	19.60	4.16	1.78	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	26.36	6.40	0.75	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	31.20	8.71	2.18	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	25.08	3.76	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	40.36	7.91	1.98	0.49	0.16	0.33	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	28.66	9.55	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	38.45	4.67	1.66	0.15	0.15	0.15	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	33.75	5.89	2.68	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	35.33	4.91	2.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	29.67	5.88	1.87	0.53	0.27	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	22.44	2.93	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	30.19	4.31	1.49	0.33	0.00	0.33	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	27.62	7.20	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	46.02	3.54	3.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	31.39	5.15	2.23	0.69	0.00	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	25.17	12.58	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	29.61	3.40	1.94	0.49	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	24.28	3.42	0.00	0.76	0.00	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	26.65	2.42	1.21	0.00	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	32.49	3.42	1.14	0.57	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	31.64	3.63	1.28	0.64	0.00	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	30.97	3.10	1.81	0.00	0.00	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	29.09	4.69	0.94	0.47	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	36.34	6.75	2.25	0.00	0.00	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	22.12	4.28	2.14	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	22.23	6.43	2.92	1.17	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	32.82	5.12	0.90	0.60	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	24.95	8.32	0.00	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	28.99	4.58	3.05	0.51	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	24.20	3.82	2.04	0.51	0.51	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	29.86	5.72	0.64	1.27	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	28.91	4.32	0.43	0.86	0.00	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	32.18	3.39	2.33	0.42	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	33.64	3.77	1.45	0.29	0.29	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	31.18	4.72	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	30.68	4.92	0.68	0.17	0.00	0.00	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	6.95	2.32	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	25.35	12.68	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	36.02	5.15	1.50	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	26.47	5.41	1.80	1.20	1.20	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	29.89	4.37	0.73	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	32.87	4.37	1.15	0.46	0.23	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	0.00	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	39.66	6.61	2.03	0.25	0.25	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	34.06	4.34	1.45	0.21	0.21	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	28.76	5.51	0.92	0.31	0.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	33.94	3.82	0.48	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	26.17	4.66	1.33	0.89	0.00	0.44	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	22.89	1.53	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	31.57	3.88	1.11	0.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	36.01	6.09	1.06	0.79	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	27.26	5.09	0.73	0.36	0.00	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	53.79	7.00	1.97	0.37	0.25	0.12	0.86
Astrocyte - cerebellum, donor2	11580-120F5	37.83	6.85	1.88	0.34	0.51	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	27.69	5.66	0.63	0.21	0.00	0.63	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	57.87	10.46	3.14	0.70	0.70	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	63.58	9.54	3.72	0.32	0.81	0.32	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	61.45	12.83	2.68	0.30	0.15	0.15	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	73.51	15.14	1.83	1.26	0.23	0.57	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	86.44	16.04	2.76	1.25	0.13	0.13	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	73.51	18.55	2.62	1.25	0.34	0.11	0.11
Basophils, donor1	12241-129G9	45.51	8.37	2.09	2.88	0.00	0.26	0.00
Basophils, donor2	12242-129H1	57.01	10.82	1.80	3.97	0.00	2.53	0.00
Basophils, donor3	12243-129H2	49.39	9.11	3.09	2.06	0.00	1.03	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	32.99	2.16	1.72	0.00	0.22	0.22	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	16.46	2.74	1.83	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	78.91	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	47.07	3.77	5.65	0.63	0.63	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	47.62	7.28	3.33	0.42	0.42	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	34.54	5.30	0.92	0.23	0.00	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	39.95	3.60	2.34	0.00	0.36	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	41.12	21.23	3.19	7.63	2.99	0.21	0.41
Burkitt's lymphoma cell line:RAJI	10476-106I8	81.28	20.96	5.82	3.73	1.40	0.47	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	79.94	14.71	6.08	2.56	0.32	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	103.42	0.00	20.68	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	31.00	5.07	1.69	2.82	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	41.57	7.98	1.86	1.67	0.00	0.37	0.00
CD14+ Monocytes, donor3	11381-118B4	36.44	6.81	1.54	1.10	0.22	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	41.32	6.79	3.40	0.85	0.00	8.77	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	48.14	9.10	2.27	0.38	0.00	5.69	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	59.50	7.23	2.63	0.66	0.00	3.62	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	43.80	10.26	3.47	1.59	0.00	0.72	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	47.37	6.64	1.81	0.60	0.00	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	62.78	7.34	4.03	1.42	0.00	0.47	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	33.48	6.03	2.18	0.50	0.00	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	35.88	3.86	1.93	0.55	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	31.24	8.18	2.98	1.49	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	22.32	4.90	2.15	0.59	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	27.78	5.16	0.53	0.36	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	32.64	4.13	1.31	0.65	0.00	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	20.13	4.21	0.94	0.94	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	35.38	3.70	0.53	2.11	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	21.08	5.55	1.11	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	31.53	5.65	3.42	0.89	0.00	0.74	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	33.52	6.39	0.80	1.00	0.00	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	38.31	4.37	1.46	0.42	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	20.36	2.75	0.69	0.23	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	22.85	2.26	1.58	0.90	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	19.64	2.18	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	51.11	7.80	2.15	0.54	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	35.42	8.72	2.44	1.05	0.00	0.70	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	53.44	8.84	1.68	0.84	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	22.05	3.49	0.55	0.55	0.00	0.55	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	25.72	8.45	0.00	1.06	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	34.22	4.83	0.00	0.44	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	27.03	4.71	1.22	0.70	0.00	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	33.08	4.83	0.37	0.37	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	34.70	5.82	0.86	1.08	0.00	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	23.34	4.09	1.23	0.41	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	21.79	3.94	1.16	1.62	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	25.29	3.71	1.39	0.93	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	41.20	3.05	1.74	0.22	0.00	0.00	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	47.12	6.01	3.00	1.15	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	50.47	4.33	3.47	0.00	0.00	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	73.66	9.81	2.80	0.47	0.00	0.16	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	52.74	6.46	1.92	0.52	0.17	0.35	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	64.44	4.68	4.01	0.89	0.00	0.45	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	49.25	4.85	3.57	1.28	0.00	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	52.26	5.93	1.54	0.88	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	55.79	6.32	3.37	0.42	0.00	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	54.87	22.36	2.03	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	50.85	14.24	0.68	6.10	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	53.85	16.57	1.04	2.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	49.57	20.79	0.00	4.26	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	71.83	15.55	1.07	0.54	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	59.66	15.44	2.81	2.81	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	56.47	18.04	0.78	3.14	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	58.00	32.96	2.64	3.95	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	99.45	18.08	1.64	4.93	0.00	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	81.25	15.96	0.73	5.80	0.00	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	98.44	16.15	1.51	6.06	1.01	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	48.49	13.33	2.02	2.02	0.00	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	38.75	8.39	2.40	1.20	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	78.32	15.06	1.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	61.24	12.92	2.81	2.25	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	87.93	12.40	2.25	1.88	0.38	0.38	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	88.84	11.95	2.25	1.58	0.45	0.00	0.45
CD4+ T Cells, donor1	11225-116C1	92.83	20.00	2.86	16.42	0.36	1.07	0.00
CD4+ T Cells, donor2	11306-117C1	75.32	16.53	1.84	14.70	0.00	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	77.16	20.43	0.61	9.45	0.00	1.52	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	70.19	14.80	1.28	1.28	0.00	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	70.07	17.52	1.35	0.67	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	78.48	18.97	0.86	2.30	0.00	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	80.12	22.28	0.47	4.74	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	82.87	24.58	0.00	2.11	0.00	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	108.78	19.78	0.00	6.59	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	41.62	14.02	1.01	1.59	0.00	0.58	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	66.77	15.59	0.85	1.86	0.00	0.85	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	55.62	14.19	1.45	0.81	0.00	0.32	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	56.04	15.24	0.00	4.48	0.00	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	64.29	20.96	0.35	2.10	0.00	0.70	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	73.92	9.24	1.76	1.76	0.00	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	68.31	14.34	0.84	3.37	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	65.45	15.79	1.45	2.29	0.00	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	72.51	17.71	0.67	2.00	0.00	0.67	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	81.31	22.57	0.00	2.45	0.27	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	100.76	17.15	1.61	4.82	0.00	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	87.87	12.55	0.00	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	71.39	20.77	2.23	2.60	0.00	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	58.27	16.90	1.52	1.52	0.00	1.08	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	59.68	16.60	1.05	1.26	0.00	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	68.76	13.15	0.00	3.54	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	58.92	17.33	0.87	3.47	0.00	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	71.04	12.20	0.44	5.67	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	88.58	26.23	0.49	4.45	0.00	0.49	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	79.39	32.31	0.92	3.69	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	72.58	23.73	0.00	4.19	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	83.36	27.69	0.83	2.22	0.28	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	96.19	19.14	1.23	1.23	0.00	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	97.02	15.40	0.00	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	79.50	15.76	0.36	2.86	0.00	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	83.10	24.93	0.00	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	79.23	24.88	1.31	12.44	0.00	0.98	0.00
CD8+ T Cells, donor2	11307-117C2	62.32	22.15	0.38	10.89	0.00	1.88	0.00
CD8+ T Cells, donor3	11383-118B6	95.95	20.96	1.51	11.36	0.25	1.77	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	69.74	13.30	1.38	0.69	0.46	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	65.42	10.78	0.72	1.68	0.00	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	61.28	10.40	0.55	1.37	0.00	0.27	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	61.24	10.81	0.60	1.20	0.00	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	76.79	9.60	0.24	2.64	0.24	1.20	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	74.13	9.32	0.68	1.82	0.23	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	55.41	9.56	0.43	2.61	0.22	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	63.43	12.90	0.26	2.11	0.26	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	63.08	10.08	0.70	0.94	0.00	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	48.00	14.49	0.60	2.72	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	52.00	8.72	0.58	2.32	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	63.41	15.19	1.07	1.60	0.00	0.27	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	59.10	12.26	0.00	4.38	0.00	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	46.45	14.12	0.00	5.01	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	65.64	9.70	0.75	5.97	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	76.35	14.05	0.36	2.16	0.00	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	81.14	13.52	0.00	3.16	0.00	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	70.94	14.38	0.47	3.30	0.00	0.47	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	60.85	13.63	0.63	3.80	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	71.35	13.84	1.23	1.23	0.00	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	70.85	11.86	0.64	2.56	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	60.43	14.15	0.38	2.68	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	60.69	14.19	0.00	3.94	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	44.63	12.10	1.51	2.27	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	76.28	24.89	0.00	11.24	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	71.34	16.79	0.00	10.49	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	68.12	22.04	1.00	12.02	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	84.08	3.66	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	32.12	7.91	0.99	0.49	0.00	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	40.51	7.05	1.16	0.32	0.00	0.00	0.32
Chondrocyte - de diff, donor1	11261-116G1	40.21	4.51	1.73	0.35	0.35	0.69	0.35
Chondrocyte - de diff, donor2	11338-117F6	26.65	4.62	1.78	0.36	0.00	1.07	0.36
Chondrocyte - de diff, donor3	11410-118E6	38.46	5.23	2.39	0.46	0.00	0.57	0.00
Chondrocyte - re diff, donor2	11339-117F7	25.07	11.64	1.79	1.79	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	39.63	8.49	2.02	1.21	0.00	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	56.35	10.56	1.84	0.34	0.23	0.57	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	44.89	7.05	2.78	0.64	0.00	0.43	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	49.47	9.56	1.59	0.71	1.33	0.27	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	48.97	8.53	3.30	1.38	0.28	0.55	0.46
Corneal Epithelial Cells, donor1	11526-119I5	25.69	3.29	0.44	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	39.82	4.55	0.00	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	30.16	5.37	1.02	0.26	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	53.49	5.78	0.66	0.00	0.00	0.66	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	49.83	3.78	0.63	0.00	0.00	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	3.45	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	42.98	4.32	0.97	0.65	0.00	0.86	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	98.73	31.77	4.44	11.96	0.68	0.34	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	101.85	23.50	3.26	12.40	1.31	0.65	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	118.08	31.94	3.39	5.32	0.48	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	47.70	9.01	3.84	0.17	0.17	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	44.01	5.28	4.69	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	52.03	11.31	3.11	0.85	0.00	0.28	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	62.12	5.90	3.15	0.39	0.00	0.00	0.79
Endothelial Cells - Artery, donor1	11264-116G4	40.14	4.94	4.65	0.58	0.00	0.58	0.00
Endothelial Cells - Artery, donor2	11341-117F9	49.64	12.00	3.29	0.47	0.00	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	48.39	8.24	2.80	0.53	0.35	0.18	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	45.66	7.98	3.55	0.66	0.00	0.66	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	52.64	8.22	4.87	0.30	0.00	1.22	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	56.66	9.30	3.38	0.56	0.00	0.56	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	41.00	4.75	2.67	0.00	0.00	0.89	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	36.45	1.04	3.64	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	35.02	5.39	2.84	0.28	0.28	0.43	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	66.82	17.21	4.40	0.40	0.40	1.20	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	45.07	4.72	3.67	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	63.74	13.05	8.32	0.99	0.50	2.73	0.75
Endothelial Cells - Umbilical vein, donor2	11324-117E1	80.39	9.56	8.91	0.87	0.22	1.09	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	71.69	9.65	9.53	0.12	0.12	1.47	0.73
Endothelial Cells - Vein, donor1	11267-116G7	46.64	10.24	3.41	0.00	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	46.80	4.89	2.10	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	43.02	8.79	5.34	0.31	0.16	0.47	0.16
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	51.16	6.60	1.65	3.30	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	24.97	3.57	3.57	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	21.99	3.18	1.71	0.00	0.49	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	29.12	4.16	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	43.51	5.75	0.82	0.41	0.00	1.23	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	22.88	2.63	2.52	0.55	0.22	0.88	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	26.76	2.60	1.30	0.22	0.00	0.43	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	36.14	5.94	2.79	0.61	0.12	1.09	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	66.05	6.41	2.87	1.50	0.00	0.41	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	37.02	5.70	1.48	0.63	0.11	1.16	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	61.66	6.32	2.63	0.26	0.26	0.79	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	46.18	4.98	1.00	0.00	0.33	2.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	43.55	9.07	1.36	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	39.41	8.34	1.52	0.76	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	18.45	4.73	1.26	0.32	0.16	0.16	0.32
Fibroblast - Cardiac, donor4	11452-119A3	51.83	7.27	2.42	0.30	0.00	0.61	0.61
Fibroblast - Cardiac, donor5	11456-119A7	44.54	11.04	2.66	0.38	0.00	0.38	0.25
Fibroblast - Cardiac, donor6	11460-119B2	41.39	7.12	1.97	0.30	0.00	0.45	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	48.50	6.83	0.94	0.13	0.00	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	50.05	6.90	0.86	0.00	0.00	1.29	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	30.76	5.86	5.86	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	57.43	8.07	3.46	0.46	0.46	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	43.76	7.46	1.87	0.17	0.00	0.00	0.17
Fibroblast - Dermal, donor1	11269-116G9	49.07	2.35	2.58	0.94	0.00	1.17	0.00
Fibroblast - Dermal, donor2	11346-117G5	41.51	5.19	2.83	0.00	0.00	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	47.39	4.84	1.69	0.60	0.00	0.73	0.12
Fibroblast - Dermal, donor4	11450-119A1	50.19	7.80	3.39	0.23	0.34	0.11	0.79
Fibroblast - Dermal, donor5	11454-119A5	60.54	10.64	4.54	0.52	0.17	0.00	0.70
Fibroblast - Dermal, donor6	11458-119A9	71.14	11.53	5.04	0.16	0.16	0.00	0.97
Fibroblast - Gingival, donor1	11237-116D4	39.77	7.29	3.33	0.83	0.00	0.42	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	51.35	4.19	4.19	1.31	0.00	2.36	0.26
Fibroblast - Gingival, donor2	11318-117D4	50.74	6.59	2.50	0.26	0.00	0.13	0.79
Fibroblast - Gingival, donor3	11394-118C8	47.28	5.80	1.64	0.19	0.00	0.58	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	39.48	10.39	1.04	0.00	0.00	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	43.70	5.99	2.11	0.35	0.00	1.41	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	58.46	10.60	3.12	1.09	0.47	0.16	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	47.33	6.36	2.98	0.54	0.00	0.41	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	87.16	3.88	8.12	0.00	0.71	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	52.36	6.87	3.07	0.88	0.15	0.15	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	53.59	7.23	3.41	0.55	0.00	0.55	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	64.50	9.10	4.94	1.21	0.22	0.55	0.33
Fibroblast - Gingival, donor9 (control)	11927-125I1	52.09	6.31	4.40	0.59	0.00	3.37	0.15
Fibroblast - Lung, donor1	11270-116H1	33.98	4.08	2.72	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	58.19	7.46	2.98	0.00	1.49	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	41.36	8.02	0.84	0.42	0.63	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	34.99	5.00	2.50	0.00	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	20.98	2.80	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	11.20	3.08	0.28	0.28	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	53.99	7.31	4.47	0.00	0.00	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	27.96	7.99	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	11.91	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	43.06	6.98	3.49	0.58	0.00	0.19	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	57.64	9.40	5.46	0.61	0.15	0.00	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	62.12	9.18	2.45	0.92	0.00	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	57.24	6.11	2.67	0.38	0.00	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	38.34	8.10	3.24	0.81	0.00	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	47.09	6.26	2.67	0.35	0.12	1.28	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	40.34	6.63	2.54	1.11	0.44	0.00	0.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	44.50	4.88	2.24	0.00	0.20	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	32.07	6.68	1.34	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	39.93	7.12	1.98	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	77.00	11.31	2.38	0.60	0.20	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	32.86	5.15	1.07	0.36	0.18	0.18	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	42.57	6.31	1.58	0.20	0.00	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	61.37	10.83	1.20	0.90	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	47.82	9.07	1.19	0.32	0.00	0.97	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	71.87	9.87	2.02	0.00	0.25	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	36.92	4.43	1.31	0.16	0.00	0.49	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	68.37	8.02	2.61	0.40	0.00	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	45.01	6.33	1.11	0.30	0.10	0.70	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	93.69	13.30	1.51	0.60	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	37.61	7.95	1.41	0.58	0.17	0.75	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	46.33	5.47	0.68	0.00	0.00	1.54	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	62.73	10.51	1.64	0.00	0.00	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	40.58	5.54	0.85	0.53	0.00	0.53	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	44.19	8.27	1.35	0.34	0.00	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	16.47	2.20	1.25	0.63	0.31	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	44.32	0.00	0.00	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	76.69	6.10	3.49	0.87	0.00	0.87	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	49.23	6.59	2.95	0.69	0.17	0.17	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	45.02	6.77	3.90	0.78	0.00	0.00	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	58.51	8.18	3.83	1.28	0.26	0.51	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	116.36	23.73	35.22	1.53	25.26	9.19	7.66
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	119.32	22.33	32.54	3.83	23.61	5.10	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	67.04	8.84	107.26	2.28	26.81	5.99	25.67
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	170.42	15.72	24.27	3.31	3.03	23.99	4.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	91.33	11.19	19.41	1.60	5.25	6.39	4.34
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	81.23	8.52	86.38	1.39	16.05	5.15	17.04
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	164.68	10.57	28.55	2.11	4.76	19.83	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	106.98	15.00	12.72	2.28	2.61	7.18	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	53.51	3.54	96.40	2.21	25.65	5.31	18.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	75.75	12.15	22.19	0.99	6.64	0.71	5.51
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	73.89	12.56	15.02	1.23	4.31	0.86	2.59
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	65.28	12.36	19.88	0.81	5.10	1.07	2.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	66.28	16.97	8.80	0.62	4.21	0.25	1.24
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	73.50	11.07	13.43	0.97	4.57	0.00	2.63
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	56.11	10.37	10.98	0.61	5.29	0.20	2.24
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	54.76	10.95	6.85	0.91	2.74	0.00	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	63.15	13.70	10.09	0.75	4.61	1.25	1.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	56.17	6.34	13.77	0.87	3.06	0.66	1.53
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	54.66	14.18	4.14	0.00	0.00	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	68.51	15.90	7.95	1.43	1.75	0.95	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	53.62	13.85	8.71	0.45	4.24	0.00	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	60.29	13.51	6.65	1.01	0.60	0.00	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	71.93	21.71	5.94	1.70	1.02	1.02	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	68.72	12.41	7.18	1.15	2.57	0.89	0.71
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	58.17	17.69	5.51	0.94	0.73	0.83	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	55.67	12.47	4.44	0.85	0.00	1.20	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	73.25	19.81	5.64	0.77	0.89	0.44	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	57.82	12.23	4.83	0.83	1.66	0.75	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	62.07	10.21	6.94	0.82	1.02	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	48.89	12.79	3.92	1.44	0.83	0.62	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	74.36	19.25	4.84	0.69	0.46	1.04	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	56.87	16.51	3.50	1.17	0.67	0.17	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	51.58	14.33	2.87	0.88	0.22	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	69.24	17.59	5.66	0.98	0.37	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	54.14	14.59	4.54	1.13	0.81	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	55.16	11.23	5.13	0.96	0.32	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	57.23	13.74	2.46	0.76	0.09	0.57	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	51.25	13.76	2.21	1.42	0.00	0.47	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	46.83	13.38	4.56	2.13	0.61	0.61	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	63.56	16.20	2.82	0.84	0.52	0.94	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	36.67	10.76	2.63	0.66	0.22	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	49.10	14.59	2.52	1.68	0.84	1.96	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	65.18	16.11	4.91	1.39	0.28	0.93	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	56.42	12.57	4.28	1.34	0.27	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	52.02	13.92	3.67	1.38	0.31	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	55.18	13.34	5.05	1.30	0.52	0.52	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	48.79	10.57	4.34	0.81	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	47.38	14.38	2.77	0.92	0.18	0.74	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	39.91	12.28	2.63	0.22	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	80.33	7.93	6.94	1.98	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	47.88	9.23	2.51	0.53	0.13	0.00	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	43.38	9.68	2.82	0.00	0.00	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	61.00	16.77	1.27	0.76	0.00	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	73.65	11.15	43.20	0.40	14.93	0.60	14.13
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	85.05	12.17	26.66	0.77	6.47	1.23	5.24
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	108.22	15.34	42.96	1.43	14.53	1.43	11.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	87.93	12.52	28.48	0.63	15.33	0.00	5.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	81.94	13.28	22.60	1.41	12.15	1.13	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	100.08	11.53	29.06	1.84	6.92	3.69	9.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	17.32	19.80	0.00	4.95	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	79.68	12.38	15.47	1.55	10.06	1.55	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	85.04	30.48	16.04	0.00	14.44	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	104.33	15.65	17.39	0.00	8.69	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	66.40	14.32	14.00	1.63	5.86	2.28	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	71.24	13.59	14.00	0.82	7.41	2.88	3.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	106.63	26.66	29.99	3.33	29.99	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	69.07	13.70	13.98	0.84	6.99	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	77.79	12.75	16.02	2.29	6.54	0.00	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	86.40	12.58	15.10	1.68	3.36	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	80.47	14.00	13.36	1.27	5.41	2.54	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	75.07	15.62	10.53	0.34	6.79	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	100.23	4.18	12.53	0.00	6.26	2.09	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	89.34	13.17	11.45	1.72	2.86	2.29	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	47.65	9.77	11.54	0.30	2.66	0.59	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	64.38	10.16	16.94	0.00	10.16	6.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	80.77	16.57	8.28	2.90	6.21	0.83	2.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	79.39	17.49	10.82	1.15	5.75	0.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	0.00	5.27	0.00	0.00	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	61.12	15.76	11.53	1.92	5.00	1.54	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	59.65	14.34	8.15	0.65	2.61	0.98	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	60.20	14.71	8.03	0.67	2.01	0.00	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	72.82	13.87	9.25	0.77	2.70	1.93	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	100.65	35.95	10.61	4.45	14.38	1.37	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	84.48	19.88	12.42	0.00	7.45	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	76.91	16.04	13.21	0.47	0.94	1.89	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	66.38	13.88	5.43	0.60	4.22	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	96.14	15.26	12.21	1.02	5.09	1.02	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	80.17	13.96	7.58	0.80	1.60	3.19	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	73.02	17.27	8.88	1.48	1.97	0.49	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	88.53	16.53	14.17	2.36	2.36	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	65.93	15.17	7.58	0.00	1.75	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	69.34	14.92	11.85	1.32	2.19	0.88	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	74.60	18.65	13.56	2.54	13.56	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	71.03	13.13	4.18	1.19	4.78	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	59.69	16.98	7.76	0.00	3.88	1.46	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	41.09	6.85	3.42	1.14	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	28.69	4.99	0.83	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	42.73	10.12	3.37	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	40.28	2.85	0.63	0.00	0.32	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	25.90	2.92	1.25	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	41.78	6.38	2.32	0.70	0.00	0.00	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	49.80	5.23	4.73	0.34	0.00	0.00	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	51.87	5.46	1.82	0.23	0.00	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	38.70	7.21	2.08	0.33	0.00	0.11	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	48.79	4.94	2.79	0.86	0.00	0.00	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	47.58	5.81	1.51	0.86	0.00	0.43	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	27.40	4.73	2.12	0.75	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	26.42	4.97	1.54	0.17	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	35.88	5.45	1.60	0.32	0.00	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	54.28	8.39	2.80	0.56	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	23.37	5.63	2.16	1.30	0.00	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	52.88	5.29	13.22	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	30.69	4.59	2.12	0.00	0.00	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	31.24	3.63	1.45	0.00	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	33.92	5.42	2.45	0.00	0.35	0.00	0.17
Hepatocyte, donor1	11523-119I2	61.74	9.68	2.42	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	72.18	12.93	0.00	0.00	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	68.10	9.20	3.07	1.84	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	69.84	20.23	2.61	4.57	0.65	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	26.39	4.37	1.05	1.05	1.57	0.70	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	35.26	4.80	3.02	0.00	0.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	82.78	6.37	0.00	6.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	6.68	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	55.38	11.08	5.54	2.77	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	7.51	0.00	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	23.74	23.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	69.20	2.56	10.25	5.13	7.69	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	0.00	0.00	4.57	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	74.72	11.37	8.12	0.00	3.25	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	38.35	13.34	0.00	1.67	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	0.00	7.26	0.00	3.63	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	67.50	13.23	5.29	2.65	3.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	65.41	6.65	3.33	2.22	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	41.91	5.24	5.24	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	56.06	12.60	1.89	0.63	0.63	0.00	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	46.40	4.64	6.19	1.55	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	29.27	0.00	0.00	0.00	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	55.56	10.98	4.52	0.65	2.58	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	61.18	12.88	1.61	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	167.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	60.30	13.04	5.70	1.63	3.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	40.72	5.88	1.68	1.26	0.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	28.74	0.00	14.37	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	55.45	10.45	7.23	2.41	1.61	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	36.01	3.69	0.92	2.77	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	0.00	15.08	15.08	0.00	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	52.87	13.69	2.36	2.83	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	40.81	7.26	0.91	0.00	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	117.94	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	67.80	19.37	6.46	5.38	3.23	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	57.17	10.16	0.00	1.27	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	82.15	16.43	32.86	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	54.20	12.75	3.83	0.64	3.19	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	61.97	9.11	0.00	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	53.55	10.71	2.86	0.71	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	69.68	29.86	0.00	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	166.79	0.00	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	62.97	9.88	4.01	1.23	0.31	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	72.00	8.78	8.78	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	110.01	15.72	0.00	6.29	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	86.23	19.47	8.34	2.09	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	70.82	4.43	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	32.42	0.00	6.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	47.08	9.59	3.49	2.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	47.25	2.25	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	48.78	10.45	3.48	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	37.34	6.40	1.07	2.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	52.65	6.93	4.16	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	96.89	17.10	8.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	58.91	19.33	0.92	0.92	2.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	39.33	0.00	6.05	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	0.00	6.21	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	32.78	8.46	1.06	1.06	0.00	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	51.49	6.53	3.43	0.41	0.65	0.33	0.16
Keratinocyte - epidermal, donor2	11349-117G8	28.11	2.34	1.17	0.59	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	42.03	5.96	1.89	0.57	0.19	0.09	0.09
Keratinocyte - oral, donor1	11251-116E9	67.66	6.24	2.84	0.79	0.23	0.00	0.34
Keratocytes, donor1	11527-119I6	91.80	8.60	3.09	0.69	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	23.44	1.17	0.00	0.00	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	63.82	5.73	1.38	0.40	0.20	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	85.72	2.20	0.00	0.00	0.00	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	36.68	6.47	4.31	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	62.86	9.23	1.61	0.12	0.12	0.12	0.35
Lens Epithelial Cells, donor3	11690-122I7	51.87	5.45	2.02	0.40	0.10	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	43.16	7.94	2.02	1.19	0.12	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	34.05	10.05	1.40	0.00	0.00	0.84	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	45.65	9.44	2.99	0.79	0.00	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	38.72	8.07	0.54	1.08	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	38.45	6.93	1.89	0.00	0.00	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	29.54	8.84	1.40	0.65	0.00	0.11	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	34.06	9.85	0.82	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	23.26	6.07	1.01	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	30.97	6.76	1.13	0.56	0.00	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	35.20	5.93	1.58	0.79	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	38.78	6.98	2.13	1.36	0.00	0.39	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	21.66	5.92	0.74	0.19	0.00	0.19	0.56
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	31.71	7.67	1.39	0.70	0.00	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	31.72	7.63	0.95	0.95	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	31.18	7.83	1.10	0.41	0.27	0.41	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	42.50	10.16	1.85	0.31	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	26.81	5.30	0.94	0.94	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	32.57	8.23	1.46	0.55	0.00	0.18	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	36.20	8.23	0.99	0.00	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	26.07	4.98	2.64	0.29	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	29.62	7.72	1.24	0.25	0.25	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	30.07	6.79	2.42	0.97	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	39.86	8.89	2.15	0.81	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	35.42	9.99	2.42	0.61	0.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	29.55	11.92	1.56	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	43.76	8.17	2.30	0.84	0.21	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	33.98	8.27	1.95	0.15	0.15	0.15	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	44.71	12.38	0.69	0.00	0.00	0.69	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	40.64	6.96	0.94	0.94	0.38	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	28.63	5.30	1.38	0.32	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	40.70	12.11	1.45	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	31.42	6.62	1.32	0.33	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	28.87	6.81	1.86	0.12	0.12	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	40.35	11.48	1.85	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	37.56	10.62	1.73	0.74	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	27.36	7.29	1.37	0.41	0.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	37.31	9.01	1.29	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	45.95	10.96	1.52	0.30	0.30	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	38.91	11.62	1.68	0.28	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	41.96	10.67	1.42	0.36	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	32.96	9.70	0.97	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	23.50	3.58	0.78	0.31	0.47	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	35.45	6.45	2.15	0.36	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	49.00	12.74	2.61	0.98	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	24.48	6.83	0.71	0.24	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	51.98	9.78	1.24	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	27.41	7.43	2.05	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	34.01	8.35	0.60	0.30	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	29.46	0.00	2.27	4.53	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	40.66	5.37	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	35.63	2.23	2.97	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	43.16	4.23	2.54	0.00	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	45.01	2.81	2.11	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	34.56	3.74	3.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	35.04	7.73	2.58	2.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	30.93	3.57	2.38	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	39.58	4.07	2.49	0.90	0.23	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	37.81	5.53	1.16	0.29	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	44.57	9.45	1.35	0.00	0.45	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	46.47	5.28	3.12	0.95	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	51.35	4.62	1.03	0.00	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	49.40	4.94	2.47	0.35	0.00	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	40.64	4.66	0.67	0.67	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	52.98	6.11	1.53	1.02	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	54.70	6.40	1.87	0.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	46.29	5.86	1.13	1.32	0.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	55.22	9.20	2.45	1.23	0.00	1.23	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	66.86	8.97	0.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	51.85	5.83	2.29	0.62	0.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	53.53	6.17	1.12	0.28	0.28	0.00	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	46.37	4.12	5.15	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	51.96	7.26	1.16	0.58	0.29	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	45.74	5.68	1.20	0.30	0.00	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	49.24	3.87	1.11	1.11	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	55.85	3.89	2.12	1.06	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	60.11	7.01	0.74	0.37	0.37	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	42.60	6.91	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	47.97	6.91	0.38	0.38	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	39.06	3.40	1.13	0.00	0.00	0.57	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	38.56	4.92	2.46	0.00	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	48.80	8.13	2.71	0.90	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	38.78	5.03	0.72	1.44	0.00	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	37.35	4.48	1.49	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	43.85	2.97	0.00	0.37	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	46.09	4.31	0.43	0.43	0.00	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	40.25	2.57	1.71	1.71	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	43.65	6.66	2.00	0.33	0.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	44.64	3.62	1.21	0.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	36.97	4.27	1.42	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	34.37	5.16	0.69	0.69	0.00	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	37.04	2.15	0.00	0.00	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	41.08	2.69	0.67	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	38.15	4.44	1.11	1.11	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	34.89	1.16	3.49	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	38.08	6.35	4.23	1.06	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	48.82	4.40	0.40	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	53.79	5.81	2.91	0.00	1.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	50.59	4.60	3.07	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	42.42	7.40	1.97	0.99	0.49	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	54.57	6.59	1.88	0.00	0.00	1.88	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	54.81	6.54	1.51	1.01	0.00	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	49.57	5.86	0.45	0.45	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	46.47	6.88	0.00	1.72	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	51.21	5.79	4.90	0.45	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	45.75	4.69	3.13	0.39	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	51.46	4.62	3.30	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	45.15	5.71	2.08	1.04	0.00	1.56	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	55.57	6.56	3.94	0.88	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	69.33	6.71	1.68	0.56	0.00	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	43.28	8.83	2.21	0.88	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	56.70	6.94	1.54	0.39	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	59.75	5.57	2.03	0.51	0.00	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	55.27	7.21	3.36	0.96	0.48	0.96	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	40.95	5.96	3.98	0.40	0.40	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	58.94	5.47	0.61	1.22	0.61	1.82	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	55.34	2.77	2.08	0.00	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	60.80	7.22	2.66	0.76	1.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	63.52	4.13	1.03	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	53.21	5.44	2.42	0.60	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	58.94	7.92	0.95	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	67.70	2.13	0.53	0.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	66.09	7.47	1.15	0.00	0.57	1.15	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	58.62	4.63	0.51	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	62.25	6.37	0.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	55.61	3.97	1.70	0.57	0.57	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	49.09	8.32	1.25	1.25	0.42	0.83	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	44.63	5.48	0.78	1.57	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	45.93	3.76	0.42	0.84	0.42	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	47.86	5.58	0.93	0.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	40.81	3.35	0.00	1.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	48.65	6.42	2.67	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	46.07	5.66	1.21	0.40	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	47.72	5.51	1.84	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	47.12	5.33	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	56.42	5.70	0.57	1.14	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	48.31	6.90	0.77	1.53	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	48.15	5.47	2.19	0.00	0.55	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	48.11	5.79	0.89	1.78	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	51.21	4.94	0.78	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	55.70	8.62	1.99	1.99	0.66	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	62.36	8.31	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	36.92	5.93	3.19	0.23	0.00	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	34.13	4.04	0.18	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	38.54	5.37	1.97	0.39	0.00	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	39.83	8.50	3.72	1.59	0.00	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	42.94	7.13	2.38	0.63	0.16	0.32	0.00
Mallassez-derived cells, donor3	11930-125I4	44.06	5.42	2.50	0.42	0.69	0.14	0.00
Mammary Epithelial Cell, donor1	11273-116H4	63.37	11.16	1.79	0.90	0.00	0.10	0.10
Mammary Epithelial Cell, donor2	11350-117G9	57.62	8.40	4.05	0.87	0.29	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	30.18	5.74	2.00	0.75	0.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	97.62	10.17	0.00	0.68	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	49.53	7.68	0.65	0.65	0.11	3.78	0.00
Mast cell, donor2	11565-120D8	82.91	6.84	1.78	1.78	0.00	5.65	0.00
Mast cell, donor3	11566-120D9	98.15	4.28	3.38	1.58	0.00	11.03	0.00
Mast cell, donor4	11567-120E1	75.17	9.75	1.77	0.89	0.00	6.03	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	56.33	9.09	0.89	0.67	0.00	2.66	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	62.45	7.59	1.17	0.58	0.00	2.92	0.00
Mast cell, expanded, donor5	11939-126A4	49.56	7.92	0.92	0.46	0.00	4.59	0.00
Mast cell, expanded, donor8	11941-126A6	49.04	8.87	2.01	1.00	0.17	4.69	0.00
Melanocyte - dark, donor1	11502-119F8	49.75	11.04	3.28	0.70	0.10	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	40.84	6.23	2.08	0.35	0.00	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	58.10	10.72	1.23	0.72	0.00	0.00	0.22
Melanocyte - light, donor1	11274-116H5	29.85	4.23	2.12	0.24	0.00	0.71	0.00
Melanocyte - light, donor2	11351-117H1	44.36	6.82	1.36	1.36	0.00	1.36	0.00
Melanocyte - light, donor3	11423-118G1	32.95	2.60	1.73	0.87	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	58.10	9.68	4.06	0.10	0.00	0.31	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	47.60	12.37	2.15	0.54	0.00	0.27	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	66.43	10.71	4.29	0.54	0.54	0.27	0.00
Meningeal Cells, donor1	11493-119E8	69.47	7.57	4.22	0.00	0.00	0.25	0.74
Meningeal Cells, donor2	11573-120E7	62.06	7.48	3.08	0.44	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	57.21	9.62	3.99	0.08	0.24	0.00	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	51.61	4.56	4.56	0.29	0.57	0.00	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	39.15	6.14	0.91	0.50	0.20	0.30	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	13.14	1.31	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	5.23	1.31	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	44.49	4.31	1.44	0.00	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	34.09	3.81	1.91	0.64	0.00	0.64	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	32.67	5.53	1.51	0.00	0.00	1.51	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	34.94	6.37	3.52	0.22	0.00	0.00	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	46.03	5.84	2.92	0.00	0.73	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	31.92	5.12	2.25	0.61	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	55.82	5.40	1.66	0.28	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	20.82	2.60	0.37	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	37.76	4.61	1.58	0.39	0.13	0.00	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	25.22	2.08	0.30	1.19	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	11.68	2.34	0.00	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	35.86	1.92	0.64	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	47.14	7.09	4.25	0.35	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	34.71	5.32	0.31	0.00	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	40.64	4.35	3.63	0.73	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	34.74	5.30	3.71	0.27	0.00	2.39	0.00
Mesothelial Cells, donor2	12156-128G5	34.03	4.50	3.50	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	41.91	5.49	2.75	0.29	0.07	1.01	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	44.56	2.70	1.35	0.00	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	48.52	5.17	1.23	0.49	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	36.51	5.01	1.77	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	65.68	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	33.16	6.20	0.62	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	33.40	5.60	1.04	0.62	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	71.80	11.58	4.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	44.05	6.51	0.25	0.00	0.00	0.75	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	40.50	3.26	1.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	35.77	6.50	0.61	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	33.26	3.17	0.00	0.40	0.00	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	32.74	5.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	32.29	5.32	0.76	0.00	0.00	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	36.85	5.26	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	27.80	2.97	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	34.07	1.84	0.92	1.84	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	27.72	4.47	0.00	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	50.30	0.00	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	27.10	2.76	0.50	0.50	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	31.37	2.61	0.95	0.48	0.00	0.24	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	44.23	3.32	0.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	23.72	3.45	0.92	0.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	27.13	2.94	1.26	0.21	0.00	0.21	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	32.61	4.08	0.82	0.41	0.20	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	26.60	3.86	1.07	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	28.01	1.33	0.89	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	61.91	10.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	22.34	1.97	0.88	0.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	34.47	1.52	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	51.37	6.63	3.31	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	42.94	4.35	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	28.53	2.06	0.59	0.00	0.00	0.59	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	34.89	5.45	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	30.27	2.88	1.44	0.48	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	32.02	1.60	1.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	56.22	6.86	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	39.55	4.51	0.50	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	38.73	0.00	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	35.47	2.19	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	38.63	6.62	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	48.67	5.76	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	37.68	5.45	0.74	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	35.49	2.09	0.70	0.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	59.67	6.63	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	31.11	3.76	1.03	0.00	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	38.95	4.81	0.44	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	62.14	5.68	1.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	27.77	5.05	1.96	0.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	44.47	6.65	0.42	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	46.62	3.50	1.17	1.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	38.91	4.83	0.30	0.30	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	35.90	5.01	1.67	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	50.53	14.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	22.17	0.92	1.85	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	46.10	1.71	1.71	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	35.79	5.53	1.24	0.28	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	31.62	4.92	1.30	0.78	0.00	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	45.90	3.00	1.29	0.86	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	53.36	4.45	1.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	30.43	4.27	0.80	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	50.89	3.29	3.29	0.30	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	32.06	4.38	1.27	0.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	27.39	4.78	1.91	0.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	43.12	4.86	2.21	0.22	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	49.30	4.17	1.14	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	33.81	2.84	1.14	0.28	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	43.75	4.18	1.72	0.25	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	58.00	6.52	1.96	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	29.11	5.00	1.76	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	44.69	6.63	3.17	0.86	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	41.21	2.89	0.82	0.41	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	31.27	2.98	1.19	0.30	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	24.95	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	44.69	8.21	0.33	0.66	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	42.08	4.21	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	54.76	5.93	1.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	51.22	5.59	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	45.44	7.51	0.38	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	34.09	5.59	1.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	46.37	5.09	1.70	0.11	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	37.57	5.16	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	37.74	4.03	1.10	0.00	0.00	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	48.22	9.33	1.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	45.43	4.28	1.07	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	7.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	35.35	5.05	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	37.53	4.22	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	42.22	2.72	2.72	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	15.89	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	26.72	2.43	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	24.17	4.53	1.51	7.55	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	222.70	22.84	0.00	28.55	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	130.50	3.26	3.26	19.57	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	85.54	0.00	0.00	9.50	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	175.69	37.65	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	35.33	5.39	1.29	0.43	0.00	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	39.20	5.75	2.09	1.05	0.52	1.57	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	73.42	6.01	2.67	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	70.95	6.68	1.25	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	30.42	6.65	3.42	0.95	0.19	0.19	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	165.97	28.73	3.19	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	55.76	4.08	0.00	0.00	0.68	1.36	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	38.59	9.19	3.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	56.92	3.77	1.67	0.00	0.00	1.67	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	48.11	5.81	2.79	0.00	0.00	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	65.67	5.67	1.89	0.27	0.00	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	76.95	9.25	3.99	0.00	0.00	0.42	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	66.02	4.96	1.99	0.00	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	35.19	2.98	3.79	0.00	0.00	0.54	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	47.38	3.63	3.17	0.00	0.00	0.23	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	69.40	4.08	1.31	0.16	0.00	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	55.22	9.48	2.73	0.55	0.00	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	74.79	4.24	3.18	0.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	64.83	3.00	1.80	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	22.97	3.61	1.64	0.33	0.00	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	50.25	3.74	2.60	0.33	0.16	0.33	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	63.85	7.23	1.94	0.00	0.00	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	61.88	4.22	5.63	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	65.28	2.30	4.14	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	88.37	5.78	6.43	0.32	0.00	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	24.83	3.45	3.79	0.69	0.00	0.00	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	27.81	2.53	5.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	65.28	7.13	2.45	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	58.43	2.54	2.96	0.00	0.00	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	43.67	1.90	3.32	0.00	0.00	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	69.54	2.15	2.15	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	85.97	6.00	1.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	68.53	9.02	2.25	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	56.35	4.36	1.59	0.40	0.00	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	61.29	3.71	4.64	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	60.54	4.92	2.65	0.76	0.00	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	56.38	3.26	2.28	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	104.15	3.05	2.61	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	78.70	11.31	3.62	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	46.74	5.29	4.41	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	58.51	3.99	1.99	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	80.86	7.44	0.99	0.00	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	74.65	4.21	2.30	0.38	0.00	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	61.70	3.63	1.81	1.51	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	55.48	5.97	2.43	0.66	0.00	0.44	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	90.13	5.42	2.71	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	0.00	5.11	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	99.99	6.71	1.83	0.00	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	61.06	3.15	2.52	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	52.96	1.21	1.21	0.30	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	55.38	7.12	0.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	24.94	2.27	3.40	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	10.12	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	32.55	3.85	2.24	0.87	0.00	0.12	0.00
Myoblast, donor2	11322-117D8	48.71	5.56	2.69	0.58	0.19	0.19	0.00
Myoblast, donor3	11398-118D3	46.58	8.07	2.69	1.18	0.00	0.17	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	37.07	14.89	0.73	5.40	0.00	0.44	0.00
Natural Killer Cells, donor1	11230-116C6	72.88	21.83	3.38	8.30	0.00	2.46	0.00
Natural Killer Cells, donor2	11311-117C6	71.47	17.49	2.71	12.36	0.00	0.90	0.00
Natural Killer Cells, donor3	11387-118C1	75.83	22.45	1.66	7.36	0.00	1.84	0.18
Neural stem cells, donor1	11275-116H6	108.16	14.52	2.90	0.73	0.36	2.54	0.36
Neural stem cells, donor2	11352-117H2	113.61	21.18	0.00	0.00	0.00	1.93	0.00
Neurons, donor1	11494-119E9	91.03	29.59	5.69	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	86.30	17.83	2.42	0.22	0.00	0.00	0.22
Neurons, donor3	11655-122E8	92.08	24.66	1.64	2.47	0.00	0.00	0.82
Neutrophils, donor1	11233-116C9	31.55	2.78	4.64	0.00	0.00	2.78	0.93
Neutrophils, donor2	11314-117C9	46.38	2.90	5.80	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	43.37	1.22	6.11	0.61	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	55.21	7.12	1.90	0.47	0.00	0.00	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	41.68	4.23	0.33	0.33	0.33	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	55.35	6.62	1.00	0.20	0.20	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	35.65	6.06	1.93	0.28	0.00	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	44.15	5.93	2.46	0.87	0.00	0.14	0.29
Olfactory epithelial cells, donor3	11935-125I9	40.86	6.47	1.48	0.11	0.00	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	48.11	6.53	2.73	0.39	0.10	0.10	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	40.92	8.43	2.41	0.00	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	28.08	3.62	1.70	0.43	0.00	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	26.29	2.29	3.43	0.00	0.00	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	23.59	4.34	1.86	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	37.91	6.06	0.59	0.59	0.20	0.39	0.20
Osteoblast, donor2	11354-117H4	54.08	18.26	1.40	0.00	0.00	0.00	0.00
Osteoblast, donor3	11426-118G4	52.96	6.58	2.67	0.89	0.00	0.00	0.00
Pancreatic stromal cells, donor1	11249-116E7	39.34	4.72	1.94	0.42	0.00	0.59	0.17
Pericytes, donor1	11491-119E6	19.25	3.45	0.33	0.11	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	23.32	5.43	0.23	0.23	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	24.62	6.51	1.83	0.20	0.20	0.20	0.00
Perineurial Cells, donor1	11499-119F5	37.64	5.43	1.36	0.11	0.00	0.00	0.23
Perineurial Cells, donor2	11579-120F4	44.35	7.27	1.66	0.37	0.09	0.00	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	81.28	13.07	2.55	3.51	0.00	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	64.89	11.26	1.71	4.65	0.24	0.49	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	72.08	15.66	1.42	3.36	0.00	0.78	0.13
Placental Epithelial Cells, donor1	11278-116H9	30.13	3.59	2.15	1.91	0.72	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	18.85	5.54	2.22	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	21.60	4.52	0.79	0.59	0.20	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	18.35	2.85	1.27	0.32	0.00	0.00	0.63
Preadipocyte - breast, donor1	11467-119B9	31.14	3.75	1.69	0.19	0.19	0.94	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	47.90	6.27	0.78	1.04	0.00	0.00	0.26
Preadipocyte - breast, donor2	11328-117E5	30.62	5.85	0.90	0.45	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	35.16	5.54	3.20	0.53	0.00	0.96	0.00
Preadipocyte - omental, donor2	11329-117E6	31.43	7.86	1.75	0.00	0.00	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	38.68	5.01	3.01	1.00	0.00	0.29	0.14
Preadipocyte - perirenal, donor1	11469-119C2	36.42	2.95	2.95	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	31.63	4.30	0.61	0.00	0.00	0.31	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	61.09	8.85	3.72	0.18	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	50.74	6.64	1.02	1.02	0.00	1.19	0.17
Preadipocyte - visceral, donor1	11280-116I2	61.01	7.54	3.73	0.47	0.19	1.21	0.19
Preadipocyte - visceral, donor2	11357-117H7	50.16	4.14	2.30	0.46	0.00	0.00	0.46
Preadipocyte - visceral, donor3	11429-118G7	53.71	7.00	2.72	0.94	0.00	0.63	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	28.06	4.83	1.96	0.91	5.58	3.32	0.30
Prostate Epithelial Cells, donor2	11331-117E8	35.88	4.60	3.93	0.68	0.14	1.08	0.00
Prostate Epithelial Cells, donor3	11404-118D9	42.25	3.12	4.04	0.24	0.18	1.22	0.06
Prostate Stromal Cells, donor1	11254-116F3	40.32	5.81	1.48	0.68	0.11	1.82	0.11
Prostate Stromal Cells, donor2	11332-117E9	45.54	3.94	3.05	0.18	0.18	0.54	0.72
Prostate Stromal Cells, donor3	11405-118E1	42.44	3.13	3.34	0.42	0.00	3.65	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	33.21	5.11	4.38	0.00	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	45.05	7.07	3.19	0.42	0.49	0.00	0.28
Renal Epithelial Cells, donor1	11517-119H5	24.35	3.04	3.55	0.51	0.51	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	24.18	7.11	9.25	0.00	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	55.58	9.32	3.60	0.32	1.06	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	36.77	6.13	5.45	0.00	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	35.17	7.41	3.64	0.40	0.00	0.00	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	61.05	7.10	3.55	0.22	0.44	0.00	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	20.63	5.99	2.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	37.19	6.16	2.20	0.44	0.66	0.88	0.22
Renal Mesangial Cells, donor2	11598-120H5	38.25	6.27	3.76	0.63	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	21.36	4.16	1.39	0.00	0.28	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	51.27	6.71	6.71	0.81	0.00	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	29.52	3.80	3.80	0.00	0.42	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	39.73	7.52	4.63	0.58	0.39	0.00	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	53.41	8.04	3.63	0.00	0.00	0.00	0.78
Retinal Pigment Epithelial Cells, donor1	11528-119I7	45.19	7.96	5.97	0.28	0.57	1.71	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	10.29	7.20	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	66.74	8.28	4.77	0.25	0.00	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	49.04	9.09	3.34	0.94	1.34	0.53	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	99.17	24.12	5.36	1.79	0.00	2.68	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	70.45	13.21	5.50	1.65	0.00	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	87.59	17.98	7.54	0.58	0.00	1.74	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	139.13	26.01	4.16	0.65	0.00	0.39	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	109.83	30.98	4.17	1.59	0.20	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	140.76	33.02	5.91	1.90	0.22	0.33	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	121.69	31.01	4.22	1.74	0.12	0.37	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	113.28	29.25	4.89	0.93	0.00	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	131.75	34.67	6.01	2.08	0.46	0.00	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	111.58	26.01	6.16	0.82	0.82	0.14	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	105.59	27.99	3.93	1.36	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	134.57	36.55	4.84	2.87	0.18	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	117.49	25.25	4.30	1.29	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	102.38	25.97	5.15	1.07	0.32	0.21	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	112.63	36.07	4.87	2.21	0.44	0.44	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	109.74	28.87	4.59	0.96	0.38	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	112.17	31.40	5.03	0.65	0.37	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	130.41	27.25	5.83	2.07	0.00	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	129.12	28.40	5.18	1.33	0.40	0.40	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	103.28	26.48	4.48	1.07	0.00	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	115.15	32.46	4.20	2.29	0.19	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	124.20	22.85	4.70	1.17	0.21	0.11	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	106.80	26.63	3.92	1.68	0.56	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	117.07	27.69	5.30	1.37	0.00	0.17	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	134.56	30.45	5.83	2.37	0.18	0.73	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	103.26	26.24	4.78	1.47	0.12	0.25	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	120.75	30.49	5.24	2.28	0.27	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	135.16	24.53	6.13	1.65	0.47	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	108.14	30.36	4.96	1.98	0.20	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	134.46	30.40	6.08	2.34	0.70	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	138.51	24.47	6.84	1.45	0.21	0.00	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	129.41	25.88	4.42	1.55	0.44	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	149.56	30.91	6.06	3.34	0.42	0.21	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	141.45	29.47	6.86	1.62	0.40	0.27	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	149.69	35.93	4.26	2.21	0.51	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	146.33	32.58	5.40	1.74	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	127.58	23.90	4.99	1.55	0.00	0.00	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	126.33	28.53	5.49	2.06	0.27	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	120.83	28.57	6.73	1.97	0.16	0.16	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	118.96	25.74	6.65	0.51	0.17	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	108.60	27.67	3.55	1.78	0.15	0.30	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	125.01	30.92	4.53	1.60	0.00	0.27	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	127.34	23.78	3.73	0.83	0.00	0.55	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	122.38	23.81	4.29	3.33	0.00	0.24	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	148.13	29.83	4.84	1.81	0.20	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	107.26	24.77	2.54	1.32	0.00	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	121.93	25.50	2.79	0.70	0.35	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	112.73	25.39	3.32	2.42	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	113.09	26.93	3.06	1.47	0.00	0.86	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	168.70	34.06	3.49	3.20	0.58	1.02	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	99.78	23.73	1.22	3.04	0.61	1.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	106.39	23.81	3.62	0.60	0.00	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	113.09	30.31	3.17	1.81	0.23	1.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	121.91	26.36	5.99	2.70	0.30	3.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	120.67	24.44	2.83	1.42	0.24	3.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	120.17	26.04	4.27	1.71	0.21	6.83	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	125.00	19.83	3.00	2.40	0.60	2.40	0.00
Schwann Cells, donor1	11498-119F4	31.60	6.58	1.32	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	47.63	0.00	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	49.07	9.20	2.19	0.22	0.44	0.00	0.22
Sebocyte, donor1	11220-116B5	58.06	10.41	4.38	0.00	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	34.93	4.60	2.76	0.46	0.46	0.92	0.00
Sebocyte, donor3	11378-118B1	45.55	4.74	5.98	0.21	0.00	0.41	0.41
Sertoli Cells, donor1	11255-116F4	41.41	8.28	1.66	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	62.14	5.65	5.65	0.00	0.00	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	48.56	7.13	2.20	0.70	0.18	0.70	0.09
Skeletal Muscle Cells, donor2	11358-117H8	26.75	5.06	0.00	0.72	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	63.54	13.38	1.67	0.00	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	52.00	7.38	2.51	0.31	0.00	0.31	0.31
Skeletal Muscle Cells, donor5	11455-119A6	45.78	7.28	2.97	0.30	0.00	0.59	0.15
Skeletal Muscle Cells, donor6	11459-119B1	62.02	5.39	4.16	0.31	0.00	0.15	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	40.95	7.43	2.65	0.76	0.25	0.76	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	41.24	5.71	2.85	0.29	0.00	0.57	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	54.47	8.63	3.27	0.30	0.40	0.60	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	58.56	8.68	1.94	0.34	0.17	0.17	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	37.64	7.96	1.45	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	50.64	5.37	1.10	0.41	0.00	0.00	0.00
Skin - palm, donor1	10286-104F7	96.70	5.37	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	47.14	5.19	3.60	0.43	0.29	0.72	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	92.42	4.09	8.18	0.82	0.00	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	45.83	3.64	2.47	0.13	0.13	0.26	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	37.25	3.61	2.36	0.28	0.14	1.53	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	58.09	5.63	1.69	0.28	0.28	1.41	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	91.13	12.90	3.59	1.27	0.42	0.21	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	61.16	4.72	2.40	0.22	0.22	1.35	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	27.16	4.32	2.47	0.00	0.00	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	59.81	4.22	1.11	0.44	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	35.86	5.29	1.18	1.18	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	52.37	9.50	3.09	0.44	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	35.05	3.94	2.76	0.00	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	35.54	6.18	3.09	1.55	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	49.04	11.01	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	32.34	5.32	2.00	0.40	0.00	0.53	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	37.90	6.21	1.77	0.66	0.00	1.11	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	45.32	5.51	1.54	0.26	0.13	0.38	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	32.88	4.56	2.60	0.33	0.33	0.33	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	47.84	5.61	1.77	0.00	0.30	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	26.34	3.42	1.99	0.14	0.00	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	23.75	3.74	2.77	0.16	0.00	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	52.06	4.57	1.83	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	39.15	5.30	1.52	0.25	0.25	0.76	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	79.57	6.12	0.00	0.00	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	34.33	5.72	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	33.77	3.98	1.77	0.74	0.29	1.03	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	31.42	4.52	1.29	0.65	0.00	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	37.47	5.35	2.73	0.52	0.21	0.10	0.94
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	35.42	5.41	1.86	0.46	0.15	0.00	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	18.32	2.16	3.23	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	45.13	9.86	2.09	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	21.17	4.10	0.68	0.00	0.34	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	39.26	4.55	1.57	0.24	0.08	0.00	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	33.31	4.53	5.13	0.40	0.10	7.85	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	45.06	7.05	2.05	0.68	0.00	0.91	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	35.02	6.04	0.60	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	60.14	8.48	10.60	1.32	0.26	0.00	1.85
Smooth Muscle Cells - Prostate, donor1	11257-116F6	43.41	7.86	1.46	0.40	0.13	0.93	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	44.70	4.63	3.13	0.25	0.25	2.00	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	22.83	3.30	2.03	0.25	0.00	0.76	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	42.97	5.28	1.06	0.45	0.15	0.30	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	33.01	1.50	0.75	0.00	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	334.68	36.18	31.01	0.00	0.00	2.58	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	36.74	5.12	2.33	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	34.33	3.53	0.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	39.17	11.60	1.25	0.31	0.00	0.94	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	19.17	1.18	1.47	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	63.15	6.41	2.83	0.42	0.33	0.08	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	45.78	4.20	0.47	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	28.50	5.61	2.16	0.43	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	29.06	5.35	0.76	0.25	0.00	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	31.97	8.46	0.19	0.56	0.38	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	51.01	6.43	1.82	0.14	0.28	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	42.48	6.12	1.26	0.42	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	13.33	0.48	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	29.11	4.16	1.96	0.73	0.00	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	48.61	4.86	2.21	0.88	0.00	2.65	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	28.67	4.97	1.76	0.29	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	39.46	5.83	2.92	0.19	0.19	0.58	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	26.45	5.02	1.32	0.53	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	22.69	2.23	2.98	1.12	0.00	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	43.12	3.95	5.75	0.00	0.36	1.44	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	35.49	5.39	3.69	0.28	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	41.75	7.88	1.58	0.39	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	26.41	2.54	2.54	1.52	0.25	1.02	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	39.13	3.59	1.60	0.80	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	41.80	4.18	2.51	0.00	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	34.38	5.50	0.92	0.00	0.00	0.46	0.00
Synoviocyte, donor1	11291-117A4	40.06	6.06	1.01	0.84	0.00	0.34	0.00
Synoviocyte, donor2	11368-117I9	40.73	5.87	1.01	0.00	0.00	1.51	0.34
Synoviocyte, donor3	11440-118H9	37.53	3.13	0.45	0.45	0.00	0.45	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	45.74	7.86	2.14	0.00	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	0.00	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	27.79	5.79	0.46	0.23	0.00	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	34.12	4.73	2.58	0.14	0.14	0.07	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	35.56	5.80	0.39	0.77	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	39.51	7.44	2.29	0.00	0.57	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	46.26	7.63	3.08	1.72	0.86	0.86	0.37
Urethra, donor2	10319-105A4	66.54	16.19	0.00	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	23.64	3.45	1.06	0.27	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	25.24	2.40	1.20	0.40	0.40	0.80	0.00
Urothelial Cells, donor3	11681-122H7	27.73	2.98	1.38	0.00	0.00	0.23	0.00
Urothelial cells, donor0	11216-116B1	40.12	4.46	2.45	0.45	0.45	0.00	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	67.62	24.91	1.78	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	88.64	11.44	1.43	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	32.17	6.16	0.00	2.74	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	45.80	15.84	2.07	1.03	0.00	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	61.59	10.46	2.32	2.32	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	76.01	14.58	4.16	2.08	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	63.33	14.68	0.92	0.00	0.00	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	42.91	6.39	0.00	2.74	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	76.36	12.21	3.08	2.10	3.45	0.12	0.62
Wilms' tumor cell line:HFWT	10597-108E3	70.40	7.92	1.76	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	41.06	6.98	8.94	1.68	2.79	0.28	1.12
achilles tendon, donor2	10292-104G4	70.26	2.07	8.27	0.00	0.00	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	46.66	14.28	2.55	2.04	1.53	0.25	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	76.39	18.34	5.80	4.18	0.70	0.70	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	83.69	26.71	3.44	4.75	2.49	0.95	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	91.97	21.50	5.17	1.90	0.54	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	65.21	11.81	7.03	0.56	0.00	0.28	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	81.42	14.59	3.81	0.63	0.42	0.21	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	69.96	11.98	1.63	2.18	0.00	0.54	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	66.98	12.78	0.88	1.32	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	76.36	19.19	2.45	0.82	0.00	0.41	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	107.17	20.58	4.66	1.55	0.00	0.78	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	63.30	11.96	3.31	0.18	0.00	0.00	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	140.42	27.30	7.80	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	91.33	16.50	2.79	1.16	0.23	0.70	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	79.22	13.98	6.99	0.52	0.00	0.26	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	75.69	14.03	4.97	0.00	0.00	0.00	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	59.95	6.97	1.86	0.93	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	59.22	11.52	1.23	0.41	0.00	0.82	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	112.04	9.21	4.60	0.31	0.00	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	64.86	8.96	0.85	1.28	0.00	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	73.09	11.83	3.03	0.91	0.00	0.00	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	86.65	11.07	4.09	0.72	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	48.11	8.02	4.90	0.22	0.00	0.00	0.89
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	90.39	12.01	2.67	1.00	0.00	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	102.20	11.15	9.29	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	82.87	11.68	10.55	0.00	0.00	0.75	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	99.44	20.50	4.36	0.44	0.87	0.44	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	133.09	16.87	1.87	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	73.48	4.71	3.77	0.71	0.24	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	56.31	8.07	3.26	0.16	0.00	0.47	0.00
adipose, donor1	10184-103D4	82.68	11.73	9.38	1.17	1.76	24.63	0.00
adipose, donor2	10185-103D5	105.03	8.52	9.33	2.43	1.22	2.84	2.03
adipose, donor3	10186-103D6	83.86	10.89	14.16	2.72	3.00	4.90	2.18
adipose, donor4	10187-103D7	95.34	13.87	48.54	1.73	14.73	3.47	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	69.76	9.47	6.79	0.32	0.32	0.00	0.32
adrenal gland, adult, pool1	10081-102A9	76.39	7.28	3.64	0.00	0.00	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	52.16	14.81	0.53	2.67	0.00	0.80	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	61.46	8.58	0.36	0.71	0.00	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	51.93	7.19	1.85	1.85	0.93	0.00	0.23
amniotic membrane cells, donor2	12236-129G4	53.42	9.13	4.06	0.34	1.35	3.72	0.00
amniotic membrane cells, donor3	12237-129G5	35.94	3.54	1.18	0.29	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	41.50	4.74	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	40.96	8.92	0.81	0.61	0.00	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	49.38	5.49	1.29	2.58	0.32	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	37.05	5.22	0.64	0.25	0.00	0.64	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	82.95	17.43	4.85	1.10	0.22	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	170.36	16.37	1.67	1.00	0.33	0.33	0.33
aorta, adult, pool1	10052-101G7	40.40	4.31	2.16	0.39	0.00	0.59	0.00
appendix, adult	10189-103D9	67.53	11.26	2.33	0.78	0.39	1.94	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	51.93	8.25	2.75	0.34	0.69	1.72	0.00
artery, adult	10190-103E1	36.68	6.79	5.43	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	57.80	10.58	2.32	1.16	0.29	0.00	0.00
b cell line:RPMI1788	10427-106D4	37.62	9.37	1.34	1.93	0.15	0.15	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	35.51	4.16	1.11	0.28	0.00	0.83	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	44.85	8.53	3.47	0.89	0.40	0.79	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	51.55	6.53	0.67	1.00	0.17	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	46.98	7.27	1.68	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	36.61	3.15	1.30	0.33	0.00	0.54	0.11
blood, adult, pool1	10053-101G8	42.08	11.07	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	35.11	2.57	0.86	0.00	0.00	0.86	0.00
bone marrow, adult	10192-103E3	68.16	9.45	0.67	1.35	0.00	0.00	2.02
brain, adult, donor1	10084-102B3	47.15	7.18	2.05	1.03	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	40.87	7.24	0.67	0.89	0.00	0.33	0.11
brain, fetal, pool1	10085-102B4	48.09	16.03	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	82.59	6.61	4.29	0.00	0.33	0.99	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	87.00	7.36	2.37	0.75	1.12	0.00	0.12
breast, adult, donor1	10080-102A8	81.44	12.00	1.26	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	48.91	6.61	2.54	0.51	0.13	0.38	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	92.15	14.22	2.78	1.86	0.31	0.00	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	43.51	2.53	2.76	1.15	0.23	0.23	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	63.18	6.29	2.91	1.45	1.94	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	90.27	13.16	15.99	0.47	0.00	0.47	0.94
carcinoid cell line:NCI-H727	10735-110B6	70.77	12.14	7.44	1.53	2.95	0.22	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	90.32	12.36	4.75	1.27	0.00	0.63	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	127.50	13.84	4.79	1.06	0.00	2.66	0.27
caudate nucleus - adult, donor10196	10177-103C6	48.36	6.91	3.45	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	42.50	8.53	0.50	0.67	0.00	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	40.50	9.17	0.00	1.53	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	41.38	5.13	1.46	3.30	0.00	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	84.48	20.39	0.00	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	67.90	16.01	1.07	2.35	0.00	0.00	0.00
cerebellum, adult, pool1	10083-102B2	31.05	13.45	1.03	1.72	0.00	0.00	0.34
cerebellum, newborn, donor10223	10357-105E6	57.29	6.64	2.49	2.49	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	48.92	4.54	1.01	2.52	0.00	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	28.50	5.12	0.73	0.00	1.46	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	85.41	13.37	2.30	0.58	0.00	0.86	0.14
cervical cancer cell line:ME-180	10553-107I4	45.74	7.46	1.49	0.33	0.00	0.33	0.00
cervix, adult, pool1	10013-101C4	56.90	7.14	4.30	0.21	0.00	1.89	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	50.16	8.36	3.07	0.14	0.00	0.00	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	62.70	2.61	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	69.97	12.18	26.60	2.73	25.35	14.54	2.36
choriocarcinoma cell line:SCH	10785-110H2	100.17	13.43	11.46	2.34	33.64	2.46	0.99
choriocarcinoma cell line:T3M-3	10618-108G6	110.05	7.12	31.31	0.71	17.79	6.40	3.79
chorionic membrane cells, donor1	12238-129G6	35.90	7.12	0.85	1.99	1.99	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	55.48	8.35	4.67	0.89	0.99	2.68	0.10
chorionic membrane cells, donor3	12240-129G8	50.55	5.49	2.20	0.55	0.55	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	49.48	17.17	0.00	8.08	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	83.37	14.02	2.31	0.96	0.00	0.38	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	129.88	21.54	3.80	1.27	0.42	0.00	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	65.74	9.24	1.28	1.28	0.51	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	73.29	14.03	1.94	0.48	0.48	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	69.23	11.20	4.07	1.22	0.41	1.43	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	64.19	8.24	2.94	0.88	0.88	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	107.12	24.76	2.87	0.52	0.26	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	62.40	8.91	2.51	1.37	0.00	0.69	0.00
clear cell carcinoma cell line:TEN	10636-108I6	45.46	6.42	0.87	0.87	0.52	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	27.09	4.03	2.01	0.18	3.66	0.55	0.00
colon carcinoma cell line:COLO-320	10420-106C6	73.36	13.68	3.80	0.00	0.76	1.52	0.38
colon, adult, donor1	10082-102B1	64.26	9.52	9.52	0.00	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	47.12	7.29	3.64	1.06	0.00	3.53	0.24
colon, fetal, donor1	10070-101I7	64.89	10.51	2.47	0.62	0.00	2.47	0.00
common myeloid progenitor CMP, donor1	12130-128D6	275.01	4.58	13.75	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	0.00	50.07	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	60.77	21.25	0.42	7.22	0.00	2.12	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	57.66	12.68	0.15	3.62	0.00	6.19	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	59.51	13.26	0.14	2.12	0.14	0.14	0.00
corpus callosum, adult, pool1	10042-101F6	59.92	6.74	1.55	0.33	0.00	0.22	0.11
cruciate ligament, donor2	10295-104G7	55.92	8.10	7.29	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	45.75	6.42	0.80	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	37.92	5.04	1.20	0.72	0.00	0.24	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	47.99	13.32	6.20	0.92	2.76	0.69	1.15
ductal cell carcinoma cell line:KLM-1	10438-106E6	55.65	5.64	2.05	0.26	0.26	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	46.94	5.78	6.50	0.72	3.13	1.93	0.72
ductus deferens, adult	10196-103E7	65.28	10.96	4.98	0.00	0.00	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	64.81	12.96	5.76	1.44	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	75.77	11.77	1.47	0.74	0.00	0.74	0.74
dura mater, adult, donor1	10041-101F5	53.02	5.04	3.22	0.74	0.08	0.25	0.33
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	37.75	17.54	4.00	17.99	4.00	9.33	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	54.31	10.46	8.17	2.29	2.29	3.73	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	58.58	4.32	2.47	0.62	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	50.55	4.84	1.21	0.30	0.91	0.61	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	64.22	4.32	1.23	0.00	0.93	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	57.79	6.57	1.31	1.31	0.00	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	61.01	7.71	5.03	1.34	2.68	0.67	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	73.04	12.87	2.17	0.91	0.18	0.91	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	32.16	2.73	4.99	0.32	2.89	0.32	0.32
epidermoid carcinoma cell line:A431	10426-106D3	64.25	12.23	4.56	0.67	1.11	0.44	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	37.40	8.25	0.88	1.65	0.22	0.22	0.00
epididymis, adult	10197-103E8	57.56	9.84	1.67	0.42	0.00	0.84	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	43.11	4.97	1.06	0.18	0.35	0.18	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	50.33	3.93	4.72	0.00	1.57	1.18	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	52.68	10.22	4.32	2.36	0.00	0.39	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	46.85	9.35	2.56	3.44	0.00	0.20	0.59
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	59.49	12.32	4.15	1.79	0.00	0.00	0.56
esophagus, adult, pool1	10015-101C6	42.90	6.16	2.12	0.64	0.00	1.27	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	80.15	7.51	0.88	0.50	0.75	3.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	55.54	2.41	2.41	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	46.29	10.52	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	28.28	2.98	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	59.62	5.73	3.44	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	51.01	1.46	4.37	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	49.83	9.41	0.76	0.76	0.00	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	51.42	7.95	4.49	0.51	0.26	0.26	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	52.71	7.83	3.80	1.19	0.00	0.00	1.42
frontal lobe, adult, pool1	10040-101F4	51.32	9.38	1.50	1.60	0.00	0.19	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	55.55	8.71	7.21	0.90	2.40	0.90	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	34.38	4.85	1.37	0.09	0.09	0.27	0.18
gall bladder, adult	10198-103E9	43.70	4.35	2.90	0.00	0.00	1.21	0.24
gamma delta positive T cells, donor1	11937-126A2	74.09	21.47	1.07	2.15	0.00	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	60.13	18.67	1.87	2.99	0.00	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	62.73	11.62	3.17	0.63	0.42	1.90	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	104.64	10.06	4.06	1.74	1.35	1.93	0.00
gastric cancer cell line:AZ521	10549-107H9	80.50	14.26	7.21	0.66	1.48	0.33	0.98
gastric cancer cell line:GSS	10560-108A2	54.00	5.49	2.75	0.00	0.00	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	90.01	23.99	6.40	2.97	6.40	3.66	0.00
giant cell carcinoma cell line:LU65	10487-107B1	61.39	6.77	1.95	0.23	0.23	0.80	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	40.87	6.02	1.26	0.28	0.42	0.56	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	68.59	8.98	1.75	2.00	0.00	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	36.20	4.22	3.06	0.63	0.42	0.21	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	35.39	5.76	2.11	0.42	0.14	0.00	0.28
glioblastoma cell line:T98G	10485-107A8	45.36	9.60	3.20	0.55	0.22	0.11	0.22
glioma cell line:GI-1	10413-106B8	36.90	10.84	2.93	1.17	0.00	2.34	0.00
globus pallidus - adult, donor10196	10175-103C4	56.86	6.56	0.73	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	57.12	8.30	0.98	0.49	0.00	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	57.51	1.37	1.37	0.00	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	39.44	7.46	2.13	1.07	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	264.29	7.34	12.24	7.34	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	5.23	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	51.52	5.44	2.88	0.00	0.32	1.28	0.00
hIPS +CCl2, biol_rep1	14383-156B9	68.87	8.26	43.62	0.46	13.77	0.92	8.26
hIPS +CCl2, biol_rep2	14384-156C1	69.50	5.49	41.15	0.46	11.89	1.83	6.40
hIPS +CCl2, biol_rep3	14385-156C2	85.66	7.09	47.66	1.29	16.10	1.93	6.44
hIPS, biol_rep1	14380-156B6	67.55	10.06	33.06	0.00	11.50	1.44	2.87
hIPS, biol_rep2	14381-156B7	70.64	6.86	34.29	0.00	17.15	0.69	6.17
hIPS, biol_rep3	14382-156B8	39.72	3.31	4.41	0.00	1.10	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	69.82	10.06	1.44	2.30	0.29	0.29	0.00
heart - mitral valve, adult	10205-103F7	37.37	4.78	2.09	0.30	0.00	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	42.62	4.71	2.61	0.52	0.00	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	74.11	3.33	2.50	0.83	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	55.50	6.33	4.90	0.41	2.45	1.22	0.20
heart, adult, diseased, donor1	10051-101G6	52.80	4.68	1.28	1.70	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	40.71	6.44	3.45	0.00	0.00	0.46	0.23
heart, fetal, pool1	10046-101G1	53.80	12.42	2.77	1.23	0.00	0.21	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	38.87	7.10	1.54	0.31	0.31	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	134.38	20.22	10.70	2.38	10.70	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	55.91	14.92	6.52	1.66	6.74	0.11	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	53.40	14.32	4.85	0.97	7.28	0.00	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	57.70	15.36	6.06	0.91	6.67	0.00	0.40
hepatoma cell line:Li-7	10484-107A7	47.27	6.90	3.89	0.22	3.45	1.00	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	65.02	12.76	5.73	2.71	0.80	0.20	0.30
hippocampus - adult, donor10196	10169-103B7	51.10	9.46	0.95	0.95	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	45.92	7.35	1.02	0.61	0.00	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	41.33	4.98	1.00	1.00	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	40.89	7.40	2.11	1.41	0.00	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	45.78	7.32	86.06	2.44	27.47	9.77	20.75
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	61.46	8.64	68.72	1.77	16.89	3.53	13.74
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	49.00	9.14	58.65	1.02	19.30	4.82	15.49
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	138.15	9.59	23.12	1.69	4.51	21.99	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	142.02	16.78	22.98	2.84	1.29	20.66	2.58
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	98.70	11.77	15.56	3.04	3.04	22.02	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	81.46	7.59	7.01	1.17	1.75	7.30	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	86.82	15.94	10.34	2.37	3.02	10.34	2.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	86.33	19.60	8.34	2.50	2.92	7.09	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	80.75	16.58	7.34	2.13	0.71	7.58	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	93.70	15.43	7.88	0.96	1.93	7.71	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	98.98	14.81	6.06	2.69	3.37	5.39	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	46.01	5.01	75.74	1.25	21.59	3.29	15.18
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	46.67	5.40	78.12	1.47	21.13	5.40	21.62
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	27.06	2.62	38.40	3.49	18.33	13.09	11.35
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	141.08	18.14	13.17	3.63	2.10	15.85	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	144.78	18.32	12.21	2.62	2.18	19.19	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	114.45	10.49	12.49	3.00	2.50	21.99	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	83.46	10.36	6.22	1.70	1.13	9.80	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	81.85	7.28	7.28	0.91	0.91	9.55	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	84.89	10.02	7.52	0.94	0.63	7.20	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	76.75	14.70	3.43	1.96	0.98	4.57	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	69.38	9.87	4.35	1.16	1.74	6.10	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	69.95	8.67	4.48	0.30	0.90	4.78	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	83.32	11.64	51.91	1.66	14.78	6.65	9.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	85.87	11.70	60.77	2.28	14.83	6.28	11.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	76.76	8.17	75.95	2.04	19.60	8.57	9.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	92.25	10.21	12.67	1.76	5.63	7.39	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	95.97	11.09	13.30	2.85	4.75	7.60	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	76.56	12.71	11.80	2.42	6.96	5.14	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	69.81	7.76	8.27	0.00	1.55	1.03	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	67.08	12.62	5.98	0.00	0.00	3.32	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	46.69	9.75	5.90	1.54	1.80	1.54	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	60.08	12.53	4.09	2.05	1.02	2.56	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	84.81	8.33	6.82	3.03	0.76	2.27	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	53.43	11.76	3.36	1.01	1.01	4.37	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	94.91	12.56	61.10	2.66	10.63	6.76	10.87
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	63.73	9.36	50.36	1.78	16.04	8.47	4.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	73.17	9.76	66.83	0.49	20.98	6.34	11.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	117.36	14.67	13.75	3.06	2.75	9.47	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	117.12	3.25	13.01	6.51	0.00	71.57	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	88.03	13.90	6.29	3.97	3.64	19.19	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	79.36	10.40	9.85	4.93	1.09	4.38	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	71.65	10.49	10.49	1.09	2.53	3.62	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	68.33	6.05	5.69	2.49	1.42	2.49	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	89.50	9.55	7.16	1.19	0.00	0.00	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	73.54	9.62	6.91	1.49	0.81	5.01	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	56.84	14.55	7.00	1.08	1.35	2.42	0.54
immature langerhans cells, donor1	11904-125F5	117.20	7.51	4.12	0.97	0.24	0.48	0.00
immature langerhans cells, donor2	11905-125F6	103.77	7.13	3.96	2.38	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	54.13	8.52	0.76	1.61	0.00	0.38	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	68.93	11.71	2.28	1.30	0.00	1.30	0.33
kidney, adult, pool1	10017-101C8	50.86	6.61	6.41	0.50	0.40	0.90	0.30
kidney, fetal, pool1	10045-101F9	69.67	11.11	2.83	0.35	0.28	0.21	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	59.93	9.52	4.26	1.28	4.54	1.56	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	40.64	4.42	1.38	0.83	0.00	0.28	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	47.53	7.89	1.65	2.75	0.00	0.18	0.00
left atrium, adult, donor1	10079-102A7	44.68	4.36	3.81	1.09	0.00	0.00	1.09
left ventricle, adult, donor1	10078-102A6	43.99	2.53	3.03	1.01	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	90.56	6.84	7.39	0.27	3.01	0.27	0.55
leiomyoma cell line:10964C	10569-108B2	34.85	3.23	3.23	1.44	0.36	2.16	0.00
leiomyoma cell line:15242A	10570-108B3	29.35	3.26	2.72	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	33.99	5.10	3.40	0.24	0.00	1.21	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	25.40	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	76.33	14.64	3.14	1.05	0.00	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	79.22	15.35	2.13	1.30	0.12	1.06	0.35
liposarcoma cell line:KMLS-1	10782-110G8	39.83	5.78	1.41	0.31	0.00	0.00	0.31
liposarcoma cell line:SW 872	10726-110A6	46.66	8.41	1.71	0.49	0.24	0.12	0.00
liver, adult, pool1	10018-101C9	55.42	6.16	3.08	0.81	0.32	0.65	0.16
liver, fetal, pool1	10086-102B5	40.45	1.88	0.00	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	44.77	5.40	1.02	0.29	0.00	0.15	0.15
locus coeruleus, adult, donor10252	10165-103B3	40.60	5.35	1.66	0.37	0.00	0.00	0.18
locus coeruleus, adult, donor10258	10375-105G6	32.45	4.51	1.13	0.28	0.00	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	29.44	6.31	1.68	0.00	0.42	0.84	0.42
lung adenocarcinoma cell line:A549	10499-107C4	23.80	3.32	1.11	0.83	0.14	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	33.78	0.69	4.83	0.69	2.07	0.00	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	67.09	6.72	2.50	0.66	1.05	0.26	0.40
lung, adult, pool1	10019-101D1	46.19	3.07	6.38	0.71	0.24	0.95	0.12
lung, fetal, donor1	10068-101I5	97.89	12.56	5.14	0.57	0.29	0.57	0.29
lung, right lower lobe, adult, donor1	10075-102A3	70.11	9.16	5.04	0.00	0.00	2.75	0.46
lymph node, adult, donor1	10077-102A5	59.64	13.25	2.37	2.84	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	61.59	18.85	5.04	2.63	0.44	0.66	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	53.13	17.05	0.91	6.34	0.75	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	107.04	13.59	5.95	1.70	0.85	1.70	0.00
mature adipocyte, donor1	12231-129F8	34.63	2.66	4.00	1.33	0.00	0.44	0.44
mature adipocyte, donor2	12232-129F9	50.22	5.19	2.08	1.04	0.00	1.45	0.00
mature adipocyte, donor3	12233-129G1	37.69	5.69	2.13	2.13	0.00	0.47	0.00
mature adipocyte, donor4	12234-129G2	31.59	4.21	0.26	1.58	0.00	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	106.98	12.63	15.96	1.19	3.10	2.62	2.86
medial frontal gyrus - adult, donor10196	10170-103B8	32.71	7.90	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	45.98	8.83	0.74	1.10	0.00	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	39.08	6.35	0.00	0.95	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	31.13	4.26	0.43	0.00	0.00	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	46.07	7.76	0.68	0.51	0.00	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	52.63	9.34	1.70	0.42	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	38.53	1.93	3.85	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	38.05	3.95	1.08	0.72	0.72	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	49.97	6.49	3.89	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	47.68	9.13	1.08	0.62	0.00	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	43.83	6.94	1.39	1.06	0.00	0.08	0.16
medulla oblongata, newborn, donor10223	10361-105F1	45.13	5.21	1.39	2.08	0.00	0.00	0.00
medulloblastoma cell line:D283 Med	10838-111E1	120.67	22.81	6.86	1.11	1.55	0.66	0.89
medulloblastoma cell line:ONS-76	10759-110E3	56.98	10.03	5.38	0.49	0.37	0.00	0.49
melanoma cell line:COLO 679	10514-107E1	51.17	16.82	4.89	3.16	0.14	5.46	0.14
melanoma cell line:G-361	10465-106H6	53.21	6.24	2.99	0.54	0.00	7.33	0.27
meningioma cell line:HKBMM	10691-109F7	32.74	5.79	0.54	0.90	0.00	0.36	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	98.69	38.77	5.29	2.64	0.00	0.88	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	159.68	59.10	9.85	1.56	1.04	0.52	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	35.90	5.98	1.84	0.31	0.00	0.31	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	23.63	6.00	0.18	0.73	0.00	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	28.16	6.63	1.66	0.00	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	26.83	5.62	0.84	0.00	0.00	0.56	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	27.54	5.20	1.16	0.39	0.00	0.58	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	41.64	6.25	0.69	0.69	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	24.37	4.29	1.89	0.17	0.00	0.17	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	28.98	5.06	1.04	0.35	0.00	1.04	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	27.99	4.51	1.72	0.40	0.00	0.40	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	29.84	6.35	0.68	0.54	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	31.44	5.41	1.28	0.57	0.00	0.43	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	33.59	5.27	2.63	0.99	0.00	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	31.13	4.98	0.69	0.42	0.00	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	26.88	5.93	0.35	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	23.68	5.10	0.41	0.20	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	31.63	5.03	2.16	0.00	0.00	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	21.72	4.97	0.93	0.10	0.10	0.21	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	26.22	4.33	3.42	0.68	0.00	0.91	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	34.40	6.29	2.10	0.84	0.42	0.00	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	32.73	5.98	1.79	0.45	0.15	1.20	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	26.78	7.70	0.96	0.26	0.00	0.09	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	37.92	9.94	1.10	0.74	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	37.77	6.01	2.29	0.86	0.29	0.86	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	63.57	5.89	3.37	1.68	0.00	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	36.08	4.11	0.46	0.00	0.00	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	30.95	4.35	0.51	0.26	0.00	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	27.75	4.97	2.36	0.52	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	30.19	5.85	1.23	0.62	0.00	2.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	27.77	5.65	0.47	0.00	0.00	0.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	32.83	5.08	1.02	1.02	0.34	1.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	27.90	3.14	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	27.80	6.49	0.00	0.00	0.46	1.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	96.61	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	33.46	5.48	0.87	0.29	0.00	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	28.56	6.25	0.89	0.67	0.00	0.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	27.64	3.36	2.16	0.48	0.00	1.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	36.67	7.33	2.93	0.00	0.00	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	28.53	5.03	1.68	0.00	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	25.79	2.05	0.82	0.41	0.00	1.64	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	31.36	3.87	2.15	0.00	0.00	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	24.61	10.94	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	15.49	5.16	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	25.01	4.22	1.95	0.32	0.00	0.32	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	18.91	1.45	1.45	1.45	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	38.91	4.26	3.73	0.53	0.00	1.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	33.53	2.45	2.45	0.00	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	29.93	3.11	2.72	0.39	0.00	0.78	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	31.48	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	34.77	0.99	0.00	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	29.65	2.37	1.19	0.00	0.00	1.19	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	28.02	4.87	0.00	0.00	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	34.84	3.17	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	31.73	7.24	1.72	0.00	0.00	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	47.28	2.15	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	39.92	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	3.44	3.44	0.00	0.00	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	24.86	4.48	1.22	0.00	0.00	1.63	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	17.48	2.38	1.59	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	25.94	5.31	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	25.25	5.30	0.31	0.00	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	29.41	5.35	4.01	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	31.93	3.55	1.18	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	7.70	5.14	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	33.04	5.51	1.38	0.69	0.00	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	30.18	2.47	0.99	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	29.16	3.36	2.24	0.00	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	31.17	5.72	1.27	0.00	0.00	0.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	37.48	6.45	2.01	1.21	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	32.71	4.36	0.00	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	39.28	3.80	2.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	40.66	6.07	1.21	0.00	0.00	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	36.15	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	32.12	3.29	1.65	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	35.92	4.76	2.78	0.40	0.00	0.79	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	33.10	4.87	2.60	0.65	0.00	1.30	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	42.78	6.11	3.06	0.00	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	37.91	7.74	0.77	0.00	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	68.75	7.09	11.81	0.47	0.24	0.24	2.36
mesothelioma cell line:ACC-MESO-4	10494-107B8	76.92	13.90	5.79	2.55	1.62	0.00	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	47.01	8.55	4.27	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	32.37	4.73	3.08	0.62	0.41	0.62	0.21
mesothelioma cell line:Mero-25	10850-111F4	24.28	5.67	2.50	0.45	1.13	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	79.70	8.07	3.67	0.24	0.24	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	63.55	11.29	3.76	0.22	0.44	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	51.51	13.14	2.10	1.84	0.00	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	63.83	11.06	3.23	0.85	0.17	1.70	0.00
mesothelioma cell line:Mero-84	10855-111F9	24.52	2.78	3.54	0.25	0.51	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	60.66	6.21	3.93	0.62	1.24	1.04	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	39.26	4.14	1.82	0.33	0.17	0.00	0.33
mesothelioma cell line:NCI-H226	10846-111E9	39.46	8.51	0.72	0.90	0.72	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	39.97	6.49	2.39	0.00	0.17	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	34.86	5.09	5.34	0.00	0.51	0.25	0.25
mesothelioma cell line:No36	10857-111G2	31.64	4.57	3.26	0.33	0.00	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	53.38	7.59	1.63	0.81	0.00	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	36.08	2.30	0.77	0.00	0.00	0.38	0.38
migratory langerhans cells, donor2	11902-125F3	55.32	5.13	2.44	0.61	0.00	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	62.46	8.26	1.62	0.72	0.00	0.18	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	45.05	10.45	3.26	0.00	0.65	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	40.90	7.63	3.18	0.42	1.91	0.00	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	55.29	4.84	1.61	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	55.76	11.23	0.57	1.71	0.00	0.38	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	69.30	11.27	1.85	1.29	0.00	0.18	0.55
myeloma cell line:PCM6	10474-106I6	48.03	13.64	0.00	2.37	0.00	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	38.05	4.06	3.04	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	39.82	12.95	0.98	2.35	0.00	0.78	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	45.91	4.01	2.79	0.11	0.11	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	38.24	2.87	3.09	0.22	0.00	0.22	0.00
nasal epithelial cells, donor2	12227-129F4	45.26	4.97	4.42	1.10	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	78.91	18.86	1.84	1.38	0.46	0.46	0.92
neuroblastoma cell line:NB-1	10539-107G8	68.29	11.97	2.62	0.37	0.00	0.00	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	74.02	17.50	3.16	2.53	1.48	6.33	0.00
neuroblastoma cell line:NH-12	10555-107I6	78.83	18.45	2.24	2.05	0.00	0.56	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	83.98	16.37	2.37	0.00	0.00	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	95.19	12.83	2.38	0.16	0.16	2.38	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	67.02	16.10	5.43	0.20	0.20	0.20	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	141.14	13.35	2.54	0.64	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	57.76	6.65	1.86	0.27	0.00	0.27	0.00
neutrophil PMN, donor1	12133-128D9	104.12	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	122.27	25.03	5.75	3.38	0.51	0.68	0.51
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	66.44	12.01	3.20	1.60	0.00	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	55.46	5.77	1.92	1.28	0.32	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	42.31	6.83	2.89	0.53	0.26	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	49.59	6.47	1.22	1.69	0.00	0.09	0.09
occipital cortex - adult, donor10196	10172-103C1	41.21	6.18	0.00	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	54.21	8.86	0.81	1.34	0.00	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	45.13	6.19	1.09	0.73	0.00	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	59.83	7.61	1.31	1.05	0.00	3.15	0.00
occipital lobe, fetal, donor1	10073-102A1	114.57	19.74	0.86	0.00	0.00	1.29	0.86
occipital pole, adult, pool1	10036-101E9	37.69	8.04	0.55	1.42	0.00	0.16	0.00
olfactory region, adult	10195-103E6	44.13	7.07	0.76	0.38	0.00	0.00	0.00
optic nerve, donor1	10277-104E7	82.04	4.00	0.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	42.60	6.61	3.99	1.03	1.37	1.82	0.91
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	53.44	5.36	5.22	0.41	0.82	0.41	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	65.02	10.67	1.52	0.85	0.00	0.68	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	43.08	5.89	1.96	1.04	0.23	0.81	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	39.98	6.76	1.76	0.59	0.00	1.18	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	41.11	5.61	1.87	0.93	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	68.07	14.42	11.24	1.27	0.21	0.64	1.27
ovary, adult, pool1	10020-101D2	50.05	7.25	1.31	0.35	0.00	0.26	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	38.13	6.05	0.55	0.00	0.37	0.00	0.00
pancreas, adult, donor1	10049-101G4	63.96	15.05	1.88	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	144.24	12.02	25.44	1.96	29.07	6.15	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	21.81	7.67	1.02	1.02	0.00	0.17	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	41.73	4.97	1.99	0.50	0.83	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	52.26	10.43	1.56	1.92	0.00	0.18	0.09
parietal cortex, adult, donor10258	10373-105G4	41.10	5.87	2.94	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	41.38	2.82	2.82	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	48.17	7.41	0.86	0.86	0.00	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	46.09	8.99	1.41	1.15	0.00	0.00	0.00
parietal lobe, fetal, donor1	10072-101I9	104.74	20.37	2.91	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	42.62	6.73	1.50	1.87	0.00	0.00	0.37
parotid gland, adult	10199-103F1	78.93	10.48	12.33	1.23	0.00	0.00	0.62
penis, adult	10200-103F2	44.04	6.45	1.07	0.00	0.00	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	58.20	5.76	6.88	0.56	0.19	1.12	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	54.05	5.10	2.62	0.15	0.44	0.29	0.44
pineal gland - adult, donor10196	10179-103C8	49.02	9.68	1.29	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	64.55	18.36	1.78	4.15	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	40.76	6.27	2.51	0.63	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	45.53	7.08	3.04	1.01	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	65.15	14.59	1.56	1.04	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	51.93	7.66	2.55	0.85	0.00	0.00	0.85
placenta, adult, pool1	10021-101D3	56.01	6.56	6.56	0.65	1.51	0.65	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	51.12	17.48	1.19	2.91	0.93	0.53	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	42.18	6.23	1.87	0.78	0.16	0.16	0.00
pons, adult, pool1	10033-101E6	41.83	7.75	2.15	1.29	0.00	0.69	0.09
postcentral gyrus, adult, pool1	10032-101E5	42.98	8.46	1.05	1.66	0.00	0.17	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	198.68	16.73	20.91	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	36.27	5.83	2.62	0.29	0.00	0.29	0.29
prostate cancer cell line:PC-3	10439-106E7	54.27	8.89	4.36	0.91	0.36	0.00	0.00
prostate, adult, pool1	10022-101D4	45.98	5.99	1.36	0.36	0.00	0.18	0.18
putamen, adult, donor10196	10176-103C5	44.62	7.55	0.00	0.71	0.00	0.00	0.00
putamen, adult, donor10252	10152-102I8	52.94	11.76	1.96	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	60.10	3.28	13.11	0.00	7.65	1.09	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	33.10	5.32	0.72	0.72	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	29.24	5.25	2.25	1.50	0.00	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	41.89	6.40	3.20	2.04	2.33	0.29	0.00
rectum, fetal, donor1	10067-101I4	75.11	13.91	4.17	1.39	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	47.91	6.15	1.48	0.85	0.21	0.42	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	34.38	2.49	0.41	0.41	0.00	0.41	0.00
retina, adult, pool1	10030-101E3	55.56	9.14	1.49	0.99	0.00	0.10	0.20
retinoblastoma cell line:Y79	10475-106I7	70.41	22.08	5.20	2.08	0.26	0.52	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	66.88	8.11	5.78	0.37	2.34	0.25	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	50.90	9.84	1.41	0.56	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	52.29	6.06	0.76	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	49.85	6.47	1.78	0.81	0.00	1.46	0.16
salivary acinar cells, donor2	11772-123I8	50.81	8.12	1.93	0.83	0.00	1.79	0.00
salivary acinar cells, donor3	11773-123I9	84.08	5.30	1.32	0.66	0.00	1.32	0.00
salivary gland, adult, pool1	10093-102C3	78.36	11.44	11.44	1.72	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	50.33	4.38	3.20	0.51	0.00	0.76	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	46.32	4.58	4.00	0.24	0.35	0.94	0.24
seminal vesicle, adult	10201-103F3	65.60	7.94	5.29	1.06	0.00	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	50.29	6.56	2.92	0.73	1.70	0.24	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	42.78	5.28	2.52	0.75	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	34.12	6.02	5.02	1.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	60.18	7.12	4.03	0.67	1.07	0.00	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	71.73	11.27	3.76	1.99	0.11	0.77	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	50.58	7.48	1.29	0.13	0.00	0.77	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	43.27	4.97	0.71	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	52.29	5.52	2.64	0.24	0.12	0.96	0.36
skeletal muscle, fetal, donor1	10066-101I3	66.33	10.05	0.00	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	230.70	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	51.13	6.31	1.26	0.63	0.00	2.52	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	80.71	17.34	4.34	1.67	0.33	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	67.14	23.96	5.67	2.84	1.58	0.32	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	122.97	16.19	7.90	2.51	1.16	1.54	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	77.30	18.13	6.76	2.14	0.49	0.66	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	84.61	14.32	15.12	1.61	1.13	0.97	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	115.50	26.59	6.32	4.36	3.70	1.53	0.44
small intestine, adult, pool1	10024-101D6	56.62	6.93	5.26	0.84	0.00	1.79	0.24
small intestine, fetal, donor1	10064-101I1	47.91	11.30	1.72	0.74	0.00	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	72.32	7.69	5.13	0.51	0.51	1.54	1.03
smooth muscle, adult, pool1	10048-101G3	42.65	3.62	1.55	0.00	0.00	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	61.91	7.24	2.68	0.54	0.00	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	43.13	3.90	1.38	0.00	0.00	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	44.55	4.73	2.37	0.39	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	29.06	0.00	0.00	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	54.89	10.37	3.05	0.00	0.00	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	41.33	3.67	4.13	1.84	0.00	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	38.38	7.17	3.29	0.15	0.00	0.00	0.00
spleen, adult, pool1	10025-101D7	41.52	11.67	2.42	1.21	0.11	0.44	0.00
spleen, fetal, pool1	10044-101F8	48.31	11.44	1.67	1.51	0.16	0.24	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	30.95	9.21	0.93	1.66	0.00	0.62	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	45.76	3.42	2.28	0.00	0.00	0.57	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	76.18	11.53	4.19	0.70	5.59	1.40	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	36.75	4.69	0.39	1.17	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	79.47	17.78	2.93	2.14	0.00	0.56	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	40.67	4.66	2.97	0.00	0.85	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	38.50	6.77	0.85	0.00	0.42	0.00	0.42
stomach, fetal, donor1	10062-101H8	73.69	3.20	2.14	0.00	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	70.07	10.25	6.84	1.14	0.00	1.14	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	49.64	4.57	0.83	0.42	0.00	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	32.59	2.59	2.59	1.03	0.00	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	48.75	7.07	0.71	0.00	0.00	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	84.83	9.86	5.04	0.92	0.23	1.38	0.00
temporal lobe, adult, pool1	10031-101E4	45.18	6.78	1.78	1.61	0.00	0.17	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	80.49	16.38	2.14	0.00	0.00	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	83.95	12.75	2.64	0.44	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	49.57	5.93	3.14	0.70	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	43.49	3.82	2.29	0.76	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	42.63	5.19	1.85	0.37	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	95.18	17.00	46.57	0.34	11.05	1.36	11.73
teratocarcinoma cell line:NCR-G1	10798-110I6	54.72	12.33	5.70	1.39	2.00	2.00	1.08
teratocarcinoma cell line:PA-1	10807-111A6	57.96	8.06	23.71	0.62	3.10	0.46	4.34
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	87.09	10.54	48.11	1.90	28.69	4.70	7.49
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	107.78	11.35	71.10	3.03	27.61	6.05	23.45
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	81.36	16.14	41.12	5.02	39.37	7.53	13.52
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	24.43	4.56	30.29	0.00	4.89	1.30	3.91
testis, adult, pool1	10026-101D8	47.89	9.56	3.22	2.25	0.43	1.18	0.32
testis, adult, pool2	10096-102C6	83.00	18.49	0.45	4.51	0.00	0.45	1.80
thalamus - adult, donor10196	10168-103B6	40.85	3.31	1.10	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	46.42	6.41	1.72	0.47	0.00	0.00	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	58.51	4.62	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	23.72	3.95	0.33	0.16	0.00	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	31.07	3.45	1.73	0.58	0.58	0.58	0.00
throat, adult	10209-103G2	49.93	5.99	1.75	1.50	0.00	2.00	0.00
throat, fetal, donor1	10061-101H7	64.29	12.80	1.83	0.61	0.30	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	121.43	13.91	4.77	0.60	0.00	0.00	0.40
thymus, adult, pool1	10027-101D9	76.45	25.95	2.19	3.48	0.80	1.39	0.10
thymus, fetal, pool1	10043-101F7	68.89	23.48	1.66	4.05	0.62	0.73	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	32.31	6.12	2.26	0.80	0.00	0.13	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	51.55	8.66	3.49	0.98	0.00	0.28	0.42
thyroid, adult, pool1	10028-101E1	57.76	10.45	1.31	1.40	0.00	0.65	0.47
thyroid, fetal, donor1	10060-101H6	82.53	7.12	1.32	0.53	0.53	0.53	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	12.32	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	51.86	7.91	2.33	0.23	0.00	1.16	0.70
tongue, fetal, donor1	10059-101H5	51.23	9.85	1.18	0.39	0.00	0.39	0.39
tonsil, adult, pool1	10047-101G2	64.91	11.52	3.01	2.70	0.30	0.10	0.00
trachea, adult, pool1	10029-101E2	52.19	5.81	3.76	0.25	0.25	0.33	0.25
trachea, fetal, donor1	10058-101H4	56.93	8.46	3.46	0.38	0.00	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	41.45	11.34	2.83	1.06	0.00	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	59.68	12.77	4.05	0.81	0.30	1.11	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	71.14	9.40	15.04	0.94	3.76	5.17	1.25
tridermal teratoma cell line:HGRT	10694-109G1	68.49	7.61	3.81	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	34.20	2.62	3.98	0.17	0.34	0.17	0.25
umbilical cord, fetal, donor1	10057-101H3	54.25	10.43	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	73.20	7.85	0.68	0.00	0.00	0.00	0.00
uterus, fetal, donor1	10055-101H1	60.92	11.26	2.05	0.00	0.00	0.00	0.51
vagina, adult	10204-103F6	54.93	8.40	1.94	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	54.58	13.37	1.53	1.97	0.22	0.66	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	33.91	7.74	0.27	0.80	0.00	0.53	0.00